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Thesis Abstract 
   Neurovascular unit (NVU) is a conceptual unit in the brain, composed of neurons, 
glial cells such as astrocytes, microvasculatures covered by pericytes and extracellular 
matrix. This warns against focusing on only neurons and indicates the importance of 
investigating interactions between neurons and other brain cells for therapeutic 
approaches for neurodegenerative diseases. Microvasculatures in NVU have 
brain-specific functions called blood-brain barrier (BBB) and limit the transport of 
drugs to neurons. Although many studies have been performed for investigating BBB 
functions, an in vitro three-dimensional (3D) NVU model has not been established 
because of the gap between in vitro cell culture microenvironments and in vivo cellular 
conditions. Therefore, the aim of this study is to establish an in vitro 3D NVU model 
using a microfluidic device. 
   Chapter 1 summarizes the background, previous studies and objectives of this study. 
   Chapter 2 summarizes materials and methods of this study. 
   Chapter 3 describes the establishment of an in vitro brain angiogenesis model 
focusing on microvasculatures in NVU. In particular, organ-specificity of endothelial 
cells (ECs) is focused on, and brain ECs and human umbilical vein endothelial cells 
(HUVECs) are cultured to construct microvasculatures. These organ-specific 
microvasculatures are compared in terms of microvascular formation processes, 
endothelial barrier functions and endothelial junction protein expressions. Consequently, 
an in vitro brain angiogenesis model is successfully established. In addition, it is found 
that endothelial barrier functions are greater in brain microvasculatures compared to 
microvasculatures formed by HUVECs. 
   Chapter 4 describes the integration of brain angiogenesis and neurogenesis models 
toward the construction of an in vitro NVU structure. First, brain ECs and mesenchymal 
stem cells are cocultured to investigate cell culture conditions for inducing angiogenesis. 
Next, the optimized culture condition for angiogenesis is applied to the culture of neural 
stem cells (NSCs), which succeeds in inducing 3D neurite extension. Finally, these 
angiogenesis and neurogenesis models are combined, which results in the construction 
of neurovascular tissues. 
Chapter 5 describes investigation of long-term culture to construct NVU tissues 
including astrocytes. NSCs differentiate into astrocytes in long-term culture, which 
allows to construct a tissue composed of neurons, astrocytes and microvasculatures. 
However, further investigation is needed to construct more physiological NVU 
structures. 
   Chapter 6 summarizes the results of this study and future perspectives. 
  
 
論  文  要  旨 
【訳題】 
オンチップ組織工学による生体外 Neurovascular Unit モデルの開発 
 
 Neurovascular Unit（NVU）とは，主にニューロン，アストロサイトなどのグ
リア細胞，ペリサイトを伴う微小血管，細胞外マトリクスから成る概念的な構
成単位である．このことは，神経変性疾患の治療に対する治療戦略として，ニ
ューロンのみに着目するのではなく，周辺の細胞との相互作用の調査を行うこ
との重要性を示唆している．NVU における微小血管には血液脳関門という脳血
管特有のバリア機能があり，ニューロンに対する薬剤の供給を制限する．これ
まで血液脳関門の機能について多くの研究が行われてきたが，生体外の脳血管
モデルは生体内の環境との乖離があり，いまだに NVU の 3次元生体外モデルは
実現していない．そこで本研究では，マイクロ流体デバイスという細胞の 3 次
元培養が可能なチップを用いて，神経幹細胞と脳の血管内皮細胞を培養し，生
体外 NVUモデルを構築することを目的とした． 
 第 1章に，本研究に関する基礎事項，従来の研究，本研究の目的を概説した． 
 第 2章に，本研究で用いた試薬類や実験手法などについてまとめて述べた． 
 第 3章では，まず NVUの中の微小血管のみに着目し，生体外血管新生モデル
の確立のために行った実験について述べた．特に血管内皮細胞の臓器特異性に
ついて着目し，脳血管内皮細胞およびヒト臍帯静脈内皮細胞を用いてそれぞれ
微小血管網の構築を行い，その構築プロセス，血管バリア機能の評価，血管内
皮細胞のジャンクションタンパク群の発現評価などを行った．その結果，生体
外脳血管新生モデルを確立するとともに，脳血管において血管バリア機能が優
れていることを見出した． 
 第 4章では，生体外 NVU構造の構築を目指し，血管新生モデルと神経新生モ
デルの統合を試みた．まず，脳血管内皮細胞と間葉系幹細胞の共培養によって
血管新生を誘導できるような細胞培養条件を検討した．次に，その培養条件下
で神経幹細胞を培養し，3次元的な神経網形成を誘導することに成功した．さら
に，血管新生と組み合わせることで，神経網および微小血管からなる神経・血
管組織の構築に成功した． 
 第 5 章では，第 4 章で述べた培養系を長期培養にすることにより，神経網と
微小血管に加えアストロサイトを含んだNVU様組織の構築に必要な培養条件を
検討した．長期培養によって神経幹細胞からアストロサイトへの分化誘導が確
認され，神経・血管・アストロサイトを含む組織の構築に成功したが，生体内
の模擬のため，さらなる検討が必要であることが示唆された． 
 第 6 章に，結論として各章の内容をまとめて研究成果を要約し，今後の展望
について述べた． 
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Chapter 1 General Introduction 
1-1 Neurovascular unit (NVU) 
The brain consumes almost 20% of all nutrients present in the blood (Zlokovic, 
2008). For the proper function of the brain, neurons always demand nutrients, mainly 
glucose, from closely-existing capillaries. Almost all neurons in human brain have 
capillaries in close proximity (Zlokovic, 2005). Astrocytes exist in close proximity 
between neurons and capillaries. This neuron-astrocyte-capillary organization is 
important for astrocytic transport of nutrients from blood to neurons, and this unique 
multicellular structure is called the neurovascular unit (NVU) defined as a structure 
composed of neurons, astrocytes, capillaries and extracellular matrix (ECM). 
The concept of NVU was proposed in the Stroke Program Review Group held in 
2001 by the National Institutes of Neurological Disorders and Stroke 
(https://www.ninds.nih.gov/) (Lo et al., 2003). The concept of NVU implies the 
importance of considering multicellular structure of NVU. The loss of neuronal 
functions causes neurodegenerative diseases such as Alzheimer’s disease and 
Parkinson’s disease. Neuronal functions are supported by surrounding other cells. It is 
important to consider interactions between neurons and other cell types in NVU for the 
further understanding of pathological states in neurodegenerative diseases (Iadecola, 
2017). 
 
1-2 Blood vessels and capillaries 
1-2-1 Fundamental features of blood vessels and capillaries 
Blood vessels are composed of endothelial cells (ECs), basement membrane (BM), 
mural cells and ECM. ECs form monolayer wall of blood vessels. BMs are various 
secreted proteins from ECs and mural cells, including type IV collagen, laminin, 
fibronectin, heparan sulfate proteoglycan and so on. Mural cells are smooth muscle cells 
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(SMCs) and pericytes. Mural cells exist closely around blood vessel wall and interact 
with endothelial monolayer. Pericytes exist around capillaries (Fig. 1-1) while SMCs 
exist around larger vessels. The average diameter of capillaries is 5–10 μm. ECM is 
composed of collagens, fibronectin, laminin, proteoglycans and so on (Frantz et al., 
2010). ECM forms net fiber structure and almost all cells attach the fiber structure to 
live and form organs. Blood vessels are distributed throughout the body and mainly 
work as a conduit of blood. Blood vessels supply oxygen and nutrients to parenchymal 
cells. ECs are connected with each other through various junctions. Leakage of 
macromolecules and cells floating in blood into parenchyma is normally restricted by 
tight junctions and adherens junctions while oxygen and nutrients are properly 
transported to organ parenchyma through vascular walls. 
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Fig. 1-1 Schematic illustrations of capillary microenvironment. 
Capillaries are small blood vessels whose diameter ranges from 5 to 10 μm. Capillaries 
are sparsely wrapped by pericytes. BM proteins localize at outer capillary surface. 
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1-2-2 Vasculogenesis and angiogenesis 
Blood vessels constitute a circulatory system throughout human body. They 
transport oxygen and nutrients throughout our body to maintain functions of each organ 
and sustain our lives. In the generation of our body through embryogenesis, there are 
two main mechanisms of creating blood vessel networks. 
Vasculogenesis is the first step to build up vascular networks (Fig. 1-2). In the 
embryonic stage, hemangioblasts, which are stem cells of ECs, proliferate to create a 
group of cells called blood island. Hemangioblasts existing in the periphery of blood 
islands differentiate into ECs and create primary vascular plexus. The series of 
processes of creating primary vascular plexus is called vasculogenesis. As a next step, 
ECs sprout from the pre-existing vascular plexus and form more complex vascular 
networks through branching and pruning processes. These growing vascular networks 
are then wrapped by other cell types such as SMCs and pericytes through interactions 
among these cell types. Pericytes wrap around capillaries to stabilize their structures. 
Capillaries wrapped by pericytes become mature and stable. This morphogenesis from 
vascular plexus to mature vascular networks is called angiogenesis. 
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Fig. 1-2 Schematic illustrations of vasculogenesis and angiogenesis. 
Vasculogenesis is the first step of vascular formation processes in which endothelial 
stem/progenitor cells expand and form primary vascular plexus. Angiogenesis is the 
following step for forming more complex vascular networks. Angiogenic processes are 
classified into sprouting, branching, pruning and pericyte coverage. 
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Angiogenesis is a multi-step morphogenesis of creating new blood vessels. In 
angiogenic processes, ECs show different morphologies and functions depending on the 
parts of growing vessels (Ribatti and Crivellato, 2012) (Fig. 1-3). As a first step, 
vascular sprouts are formed by leading ECs. these ECs are called tip cells (Gerhardt et 
al., 2003). Tip cells exist at the front edge of vascular sprouts and guide other ECs to 
elongate vascular sprouts. Tip cells extend filopodial structures, which sense guidance 
cues such as vascular endothelial growth factor (VEGF) (Ruhrberg et al., 2002). ECs 
following tip cells are called stalk cells, which proliferate and form vascular lumen 
structures. The selection of tip cells out of pre-existing vascular ECs is performed by 
signaling processes between VEGF and VEGF receptor 2 (VEGFR2), one of the 
receptors for VEGF (Bentley et al., 2014). ECs constituting vascular monolayer have 
VEGFR2. When VEGF bind VEGFR2 in ECs, these ECs activate Notch receptor in 
adjacent ECs by supplying delta-like ligand 4 (Dll4). ECs whose Notch receptors are 
activated by Dll4 behave like stalk cells while ECs which have high VEGF/VEGFR2 
signaling level stay located at the leading edge of vascular sprouts as tip cells. Position 
changes between tip cells and stalk cells can happen depending on the balance between 
VEGF/VEGFR2 signaling and Dll4/Notch signaling. ECs residing in the pre-existing 
capillary with a stable morphology are called phalanx cells. Phalanx cells have 
VEGFR1, which acts as a suppressor of VEGF binding to VEGFR2. Phalanx cells 
contribute to stop VEGF/VEGFR2 signaling and finish angiogenic processes (Bautch, 
2009). 
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Fig. 1-3 Types of ECs in processes of angiogenesis. 
Tip cells are leading cells of growing vasculatures and extend filopodial structures 
sensing angiogenic factors. Stalk cells are proliferating cells in growing vasculatures. 
Stalk cells form vascular lumen structures. Phalanx cells exist in the root of growing 
vessels and contribute to finish angiogenic processes.  
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VEGF promotes EC proliferation, inhibits EC apoptosis and increase endothelial 
permeability. VEGF regulates vascular development throughout embryogenesis. The 
expression of VEGF is induced by hypoxic conditions. Especially, hypoxia inducible 
factor-1α (HIF-1α) promotes the expression of VEGF (Zimna and Kurpisz, 2015). 
Growing capillaries become mature through interactions between ECs and pericytes. 
ECs secrete platelet-derived growth factor-B (PDGF-B) to recruit pericytes. Pericytes 
have PDGF receptor-β (PDGFR-β). Proliferation and migration of pericyte progenitor 
cells are promoted through PDGF/PDGFR-β signaling, resulting in pericyte covering 
around growing endothelial tubes. 
Angiopoietin-1 (Ang-1) is a major angiogenic factor to promote vascular maturation 
(Ribatti et al., 2011) (Fig. 1-4). Ang-1 is secreted by pericytes and binds to endothelial 
Tie-2, a receptor for Ang-1. Angiopoietin-2 (Ang-2) is expressed in ECs and acts as a 
de-stabilizing factor of vessels. VEGF increases the production of Ang-2 by ECs, and 
Ang-2 binds to pericyte Tie-2 receptor, resulting in the dissociation of pericytes from 
vessels. In this state, VEGF induces angiogenesis by stimulating ECs without pericytes. 
ECs without the coverage of pericytes and stimulus of VEGF undergo apoptosis. 
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Fig. 1-4 Interactions between ECs and pericytes. 
Ang-1 secreted by pericytes binds to endothelial Tie-2, which promotes pericyte 
association and capillary maturation. Endothelial Ang-2 binds to Tie-2 in pericytes, 
which generates pericyte dissociation. ECs without pericyte coverage can elongate 
vascular sprouts toward the region with abundant angiogenic factors such as VEGF.  
  
Y
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1-3 Extracellular matrix (ECM) 
ECM is a scaffold of organs and has fiber network structures. ECMs are essential for 
cells to live and function in every organ. Cells attach to ECM structure through integrins. 
Cell–ECM attachment through integrins is important for cell–cell or cell–ECM 
interactions. Main components of ECM are collagens, fibronectin, laminin, 
proteoglycans (Frantz et al., 2010). The components of ECM are different in every 
organ. In general, collagen I and fibronectin are abundant in many organs. However, 
brain ECM has much less collagen I and fibronectin (Bonneh-Barkay and Wiley, 2009; 
Zimmermann and Dours-Zimmermann, 2008). Hyaluronan is abundant in brain ECM 
and various proteoglycans bind to hyaluronan. Brain cells attach to these proteoglycans. 
 
1-4 Mesenchymal stem cell (MSC) 
Mesenchymal stem cells (MSCs) exist in many tissues, and are isolated from brain, 
spleen, liver, kidney, lung, thymus and pancreas (Lai et al., 2015). MSCs are originally 
defined as multipotent stem cells which have an ability to differentiate into adipocytes, 
chondrocytes and osteocytes (Lai et al., 2015). MSCs are now known to differentiate 
into stromal support cells and secrete factors to support other cells (Lai et al., 2015; 
Volarevic et al., 2011). In particular, MSCs are known to have some effects on 
angiogenesis (Bronckaers et al., 2014; Nassiri and Rahbarghazi, 2014; Volarevic et al., 
2011). MSCs secrete VEGF, basic fibroblast growth factor (bFGF), insulin-like growth 
factor-1 (IGF-1) and PDGF to support EC survival and promote angiogenesis in a 
paracrine manner. It was reported that co-implantation of ECs and mesenchymal 
precursor cells leaded to the formation of long-lasting blood vessels in mice (Koike et 
al., 2004). The implanted mesenchymal precursor cells expressed mural cell marker, 
suggesting that MSCs can differentiate into pericytes. In addition to the proangiogenic 
effects of MSCs, MSCs are also known to promote endothelial junction protein 
expressions such as vascular endothelial cadherin (VE-cadherin) and Claudin-1 in a 
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juxtacrine manner (Menge et al., 2013; Nassiri and Rahbarghazi, 2014). MSCs can 
inhibit angiogenic processes by enhancing vascular integrity. Taken together, MSCs 
have both positive effects and negative effects on angiogenesis and play important roles 
throughout angiogenic processes. The relationship between MSCs and pericytes still 
remains to be elucidated. However, some previous studies reported that MSCs and 
pericytes have many common features (Caplan, 2017; de Souza et al., 2016). 
 
1-5 Blood-brain barrier (BBB) 
1-5-1 Fundamental features of BBB 
The blood-brain barrier (BBB) is a brain-specific endothelial barrier. ECs 
constituting brain microvasculatures are connected with each other by tight junction 
proteins and strictly regulate the transport of oxygen and nutrients to brain parenchyma. 
Brain microvasculatures are formed by ECs, pericytes and astrocytes (Fig. 1-5). 
Brain microvasculatures are wrapped by pericytes and both ECs and pericytes are 
surrounded by BM. Astrocytic endfeet ensheath ECs and pericytes. BMs are composed 
of different proteins including type IV collagen, laminin, nidogen and so on (Thomsen 
et al., 2017). These BM proteins are secreted by ECs and pericytes. 
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Fig. 1-5 BBB microenvironment. 
ECs are sealed with each other by tight junction proteins and form capillary lumen. 
Pericytes wrap capillary lumen structures. Basement membranes ensheath both ECs and 
pericytes. Astrocytic endfeet wrap ECs and pericytes from further outside. 
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1-5-2 BBB molecules 
Brain ECs are connected with each other by tight junction proteins. Tight junction 
proteins expressed in a brain are occludin, claudin 1, claudin 3, claudin 5 and claudin 12, 
and tight junction accessory proteins, ZO-1, ZO-2 and ZO-3, are also expressed in 
endothelial intercellular region (Reinhold and Rittner, 2017; Tietz and Engelhardt, 
2015). In addition, adherens junction proteins such as platelet endothelial cell adhesion 
molecule (PECAM-1) and VE-cadherin are known to regulate BBB functions (Gavard 
and Gutkind, 2006). 
 
1-5-3 BBB transport pathways 
Previous studies investigated BBB-specific transport pathways (Abbott et al., 2010; 
Sweeney et al., 2018). ECs connected by tight junctions strictly prohibit the passage of 
substances through endothelial monolayer as a paracellular route. While ECs of brain 
microvasculatures have low rate of paracellular and transcellular transport, they have 
specific transporters and receptors for the entry of specific substances into brain 
parenchyma. BBB protects neurons from neurotoxins existing in blood circulation and 
nurture them by supplying nutrients. O2 and CO2 cross the BBB by simple diffusion. 
Water is transported via water channels called aquaporin (AQP) receptors. Glucose, 
which is the main energy source of a brain, is transported by glucose transporter 
isotype-1 (Glut1). Brain ECs highly express Glut-1 protein. Glucose transport depends 
on the concentration gradient between blood and brain parenchyma. Peptides and 
proteins are transported via receptor-mediated transcytosis. The transport of amino acids, 
hormones and vitamins is performed by carrier-mediated transport. 
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1-6 Neural stem cell (NSC) 
The brain is composed of neurons, glial cells including astrocytes and 
oligodendrocytes, blood vessels and ECM. Neurons, astrocytes and oligodendrocytes 
are generated by the same stem cell source called neural stem cell (NSC). While NSCs 
can generate neurons, astrocytes and oligodendrocytes, NSCs can divide symmetrically 
to generate the same stem cell (Ahmed, 2009; Temple, 2001). Undifferentiated cells 
which can self-renew and generate neurons, astrocytes and oligodendrocytes are defined 
as NSCs. Cultured NSCs also have an ability to generate differentiated cells (Fig. 1-6 A, 
B, C) while they can proliferate symmetrically (Fig. 1-6 D, E). 
In terms of cultured NSC differentiation, previous in vitro studies investigated 
effects of soluble factors on the NSC differentiation into neuronal or glial lineages 
(Bhattacharya et al., 2008; Chen et al., 2013). For example, it was reported that 
brain-derived neurotrophic factor (BDNF) promoted NSC proliferation in a 
dose-dependent manner, and BDNF effectively promoted neuronal and oligodendrocytic 
differentiation (Chen et al., 2013). In terms of retinal stem cell differentiation, ciliary 
neurotrophic factor (CNTF) have concentration-dependent effects on neuronal or glial 
differentiation (Bhattacharya et al., 2008). It was reported that low concentration of 
CNTF induced neuronal differentiation while high concentration of CNTF induced glial 
differentiation. Fetal bovine serum (FBS), which is a widely-used essential supplement 
containing many factors required for cell growth and survival (Brunner et al., 2010) was 
also reported to have different effects on NSC differentiation (Hu et al., 2013; Hung and 
Young, 2006). These studies reported that FBS promoted NSC differentiation into 
astrocytes, not neurons. Taken together, previous in vitro studies suggested that some 
additional factors in NSC culture medium can promote neuronal or glial differentiation, 
further suggesting that specially-designed growth factor cocktail can be used for the 
desired expansion of neuronal and glial lineages in NSC culture. 
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Fig. 1-6 Neural stem cell culture. (A: neurons, B: astrocytes, C: oligodendrocytes, D, 
E: neural stem cells) (Scale bar, 50 μm) 
NSCs were cultured using culture dishes for 14 days. Immunofluorescence staining was 
performed for differentiated cells (A, B, C) and undifferentiated stem cells (D, E). NSCs 
have an ability to generate differentiated cells in addition to the ability of self-renewal. 
Antibodies used here are described in chapter 2. 
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1-7 Organ-specific ECs 
Every organ has its own vascular characteristics and patterning that are generated 
through interactions between ECs and parenchymal cells (Géraud et al., 2014). ECs in 
different organs are heterogeneous depending on organ-specific functions. Differences 
of ECs were previously reported (Géraud et al., 2014; Rafii et al., 2016). ECs are 
classified into three groups; continuous non-fenestrated ECs, continuous fenestrated 
ECs and discontinuous ECs. For example, brain ECs are continuous non-fenestrated 
ECs. ECs in choroid plexus are continuous and fenestrated. Liver sinusoidal ECs are 
discontinuous. Brain ECs strictly restrain the passage of molecules over 1 nm in size, 
while liver sinusoidal ECs allow permeation of molecules of 60 nm in size (Géraud et 
al., 2014). 
ECs always interact with parenchymal cells. Organ-specific ECs are different not 
only in terms of fenestrae but also in terms of abilities to secrete angiocrine factors. 
Angiocrine factors are secreted by ECs and can stimulate organ-repair of damaged or 
diseased organs. A previous study showed that expression profiles of angiocrine factors 
in ECs were different among various organs (Nolan et al., 2013). 
These differences of organ-specific ECs are not negligible when engineering 
multicellular structure such as BBB. To mimic microvascular environment by a tissue 
engineering approach, in which ECs interact with parenchymal cells, organ-specific ECs 
derived from the target organ need to be used for the recapitulation of the multicellular 
organization and its formation processes. 
 
1-8 In vitro vasculogenesis/angiogenesis models 
Previous studies reported in vitro vasculogenesis and angiogenesis models based on 
microfluidic cell culture systems (Kim et al., 2015, 2013; Lim et al., 2013; Moya et al., 
2013). Microfluidic devices are made of polydimethylsiloxane (PDMS) and have 
designed microchannels. Microfluidic devices enabled us to culture cells 
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three-dimensionally within injected ECM scaffolds in the devices. By culturing ECs in 
ECM scaffolds such as collagen and fibrin and supplying growth factors, vascular 
formation can be induced through vasculogenesis or angiogenesis processes. 
In previous studies, vascular formation was demonstrated by ECs, and most of these 
studies used human umbilical vein endothelial cells (HUVECs) (Kim et al., 2015, 2013; 
Lim et al., 2013). Vascular formation was induced within a week. Engineered vascular 
networks expressed not only endothelial junction markers such as VE cadherin, but also 
expressed basement membrane proteins, which were signs for the maturation of 
engineered vascular networks. 
Functions of engineered vasculatures were also investigated. Especially, endothelial 
barrier function was analyzed. To analyze the barrier function of engineered 
vasculatures, it is needed to perfuse fluorescent dextran solution into the vasculatures. 
Previous studies successfully perfused the dextran solution into the engineered 
vasculature, and furthermore, the passage of the solution through the vascular wall was 
analyzed to measure the endothelial barrier function (Bang et al., 2017; Bichsel et al., 
2015; Lee et al., 2014; Sobrino et al., 2016). 
The construction of vascular networks and the perfusion of solution into the 
networks were of great importance for fundamental studies of vascular biology and drug 
screening studies. However, engineering of capillary-level microvascular networks with 
the coverage of pericytes has not been realized. In addition, as far as I know, in vitro 
BBB model of functional brain microvascular networks has not been reported while 
most previous studies were performed with HUVECs. Until now, previous in vitro BBB 
models have investigated endothelial barrier functions with/without pericytes and 
astrocytes in 2D-based cell culture systems. 
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1-9 In vitro BBB models 
The main components of BBB are ECs, astrocytes, pericytes and BMs. ECs in BBB 
express tight junction proteins, and pericytes and astrocytes closely exist around ECs. 
Previous studies focused on this characteristic morphology of brain microvasculatures 
and demonstrated BBB microenvironment by culturing these cell types. 
Transwell cell culture system has been mostly used as an in vitro BBB model 
(Banerjee et al., 2016; Bicker et al., 2014) (Fig. 1-7). Transwell system is a combination 
of well plates and semipermeable membrane inserts. Cells can be cultured on the top 
surface of the insert, the bottom surface of the insert and the bottom of wells. To mimic 
the in vivo microenvironment, ECs are basically cultured on the top surface of the insert. 
When ECs are cocultured with pericyte or astrocyte, pericytes or astrocytes are cultured 
on the bottom surface of the insert or the bottom of the well. Tri-culture system is 
realized by culturing ECs on the top surface of the insert and culturing other cell types 
on the bottom surface of the insert or the bottom of the well, which is a mimicry of in 
vivo BBB microvascular environment. BM proteins such as laminin or collagen IV can 
be coated on the top surface of the insert before seeding ECs on the insert. Transwell 
cell culture system not only mimics the in vivo brain microvascular environment, but 
also is useful for analyzing interactions among these cell types in paracrine manner. 
  Using Transwell cell culture system, endothelial barrier functions have been 
investigated. Transendothelial electrical resistance (TEER), which represents the 
resistance towards ion diffusion through endothelial monolayer, has been analyzed in 
the Transwell cell culture system to estimate endothelial barrier functions. This analysis 
is realized by employing two electrodes in apical side and basal side of EC monolayer 
respectively. Previous studies demonstrated that astrocytes or pericytes augmented the 
endothelial barrier functions estimated by TEER analysis in Transwell coculture and 
tri-culture systems. 
Although previous in vitro BBB models have established a platform to investigate 
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interactions among ECs, astrocytes and pericytes in terms of endothelial barrier 
functions, there is still a gap between in vitro BBB models and native EC conditions in 
vivo (Bicker et al., 2014). Native in vivo capillaries are three-dimensional, while ECs in 
previous in vitro BBB models formed 2D monolayer on a culture substrate. In addition, 
ECs are covered by pericytes and astrocytic endfeet and the percentage of pericyte 
coverage around capillaries are the highest in the brain compared to the other organs 
(Daneman et al., 2010; Keaney and Campbell, 2015; Thomsen et al., 2017). These 
fundamental features of brain capillaries were not included in previous in vitro studies, 
highlighting the disparity between in vitro BBB models and native EC conditions in 
vivo. 
Instead of Transwell cell culture system, a three-dimensional in vitro BBB model 
has been reported using a microfluidic cell culture system (Adriani et al., 2017). This 
study focused on the organization of the in vivo NVU structure in which astrocytes lie 
between neurons and microvasculatures. To mimic this organization, neurons and 
astrocytes were seeded within two adjacent collagen gel channels and ECs were seeded 
in medium channel to form EC monolayer. This study demonstrated that cultured 
neurons showed neurite elongation and exhibited neuronal activity. Endothelial barrier 
functions were analyzed by introducing fluorescent dextran solution into the EC-coated 
microchannel. However, this study implied some difficulties in engineering functional 
NVU structures. One was the difficulty in the mimicry of the NVU organization. This 
study indeed mimicked the cell arrangement composed of neurons, astrocytes and 
microvasculatures by seeding these cells in adjacent microchannels. However, these cell 
types were cultured within compartmentalized gel scaffolds respectively while 
astrocytes closely exist between neurons and microvasculatures in vivo. Another 
difficulty was the analysis of endothelial barrier functions. Permeability coefficients 
were calculated based on the fluorescence intensity of introduced fluorescent dextran 
into the EC-coated microchannel. However, cultured ECs formed monolayer, not lumen 
structures, and consequently had relatively large permeability coefficients compared to 
Chapter 1 General Introduction 
20 
 
previous studies. In addition, permeability coefficients were smaller in EC monoculture 
condition than coculture condition with neurons and astrocytes. This result contradicted 
previous reports that astrocytes augmented endothelial barrier functions performed by 
Transwell cell culture system and TEER approach. It is still challenging to construct a 
functional 3D NVU structure in vitro. 
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Fig. 1-7 Previous in vitro BBB model using Transwell cell culture system. 
ECs were cultured in Transwell system and endothelial barrier functions were estimated 
by TEER analysis, which is the measurement of electrical resistance across an 
endothelial monolayer. Endothelial barrier function is augmented by culturing ECs with 
astrocytes and pericytes. 
  
V
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1-10 Application of in vitro BBB models to drug screening studies 
   One of the main objectives of establishing an in vitro BBB model is the technical 
development to investigate the drug delivery to brain parenchyma. BBB excludes 
almost 100% of large molecules (>500 Da) from the brain parenchyma and more than 
98% of all small molecules (Pardridge W., 2005). Only 7% of drugs for brain diseases 
in clinical development reach the marketplace (Booth and Kim, 2012). The difficulty in 
the prediction of BBB passage makes it quite difficult to develop a new drug for 
neurodegenerative diseases. To overcome the difficulty, an in vitro BBB model as a tool 
of testing drug efficacy is needed. 
   In vitro disease models were reported previously. For example, pathological states of 
Alzheimer’s disease (AD) were mimicked in an in vitro manner (Park et al., 2015). 
Neural progenitor cells were cultured in a microfluidic device which has a series of 
hemisphere wells on the bottom of a microfluidic channel. These cells were cultured in 
hemisphere wells as spheroid culture. A shear flow was applied in the channel. As a 
result, the shear flow enhanced differentiation of neural progenitor cells into neurons 
and the formation of neuronal networks among hemisphere wells. In pathological states 
of AD, the accumulation of amyloid-β (Aβ) is widely recognized. When Aβ was added 
to the cell culture medium, viabilities and connectivity of neurons were decreased 
especially in flow condition compared to static condition. This previous study 
investigated the effects of fluid flow and Aβ protein toxicity on neurospheroids and 
suggested the potential of the in vitro model as a drug screening model. 
   Another previous study established an in vitro BBB model focusing on the transport 
of solutes through endothelial monolayer cultured in a microfluidic channel, in which 
fluid flow can be applied (Booth and Kim, 2012). The fluid flow can be applied by the 
connection of a pump system to the microfluidic cell culture system. This previous 
study reported that fluid flow augmented the endothelial barrier function measured by 
TEER approach. In addition, ECs were exposed to histamine, known as an 
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inflammatory mediator for BBB disruption, resulting in the temporal disruption of the 
endothelial barrier function. This in vitro BBB model can be used as a tool for testing 
effects of barrier-enhancing or barrier-opening drugs. 
   Previous in vitro drug screening studies recapitulated some characteristics of 
pathological states or brain endothelial barrier functions. However, previous in vitro 
disease models and BBB models have some limitations, which prevents the mimicry of 
in vivo 3D characteristics of the BBB. Previous in vitro disease models have been 
performed using only neural cells, and mimicking the BBB has not been realized (Yi et 
al., 2015). In addition, there are many BBB studies performed using rodent cells or in 
vivo rodent models. However, these models reflect only some aspects of human 
neurodegenerative diseases because of species differences. Therefore, to fully 
understand the pathology of human diseases and the prediction of drug efficacy, human 
cell-based in vitro BBB model is needed, which will potentially be of great use for drug 
screening studies. 
 
1-11 Objectives 
The final goal of this thesis is the engineering of an NVU structure (Fig. 1-8). Main 
cellular components of NVU are ECs, pericytes, neurons and astrocytes. Morphological 
features of NVU include microvascular networks, coverage of pericytes and astrocytic 
endfeet around microvasculatures and neighboring neural networks, which generate 
neuron-astrocyte-microvascular system. If we can establish a cell culture system of 
NVU, we can possibly apply the system to studies for neurodegenerative diseases such 
as Alzheimer’s disease and Parkinson’s disease by a drug screening approach or by a 
recapitulation of pathological processes and the investigation of the processes. 
Previous in vitro NVU models have mainly focused on endothelial barrier functions 
specific for brain microvasculatures using Transwell cell culture system. In these studies, 
cellular microenvironment of BBB was mimicked, and endothelial barrier functions 
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were estimated by TEER approach. However, there is still a gap between the cellular 
microenvironment in the Transwell system and in vivo BBB microenvironment. In vivo 
complex microvascular structure has neither been considered in previous in vitro cell 
culture systems nor has been engineered by a tissue engineering approach. 
One of the potential approaches of the engineering NVU structure in vitro is a 
microfluidic device. Microfluidic device has a set of microchannels designed to realize 
specific features of a target tissue or to investigate interactions among different cell 
types. Tissue engineering approaches can be performed using microfluidic devices 
because of the capability of culturing cells three-dimensionally within ECM scaffolds to 
investigate formation processes of a target tissue or to recapitulate morphological 
features of a target tissue. 
To achieve the engineering of functional NVU organization, it is quite important to 
construct the characteristic structure of NVU including the features of BBB. In this 
organization, capillary networks can be engineered through the recapitulation of 
angiogenic processes. As well as capillary networks, neural and glial networks can be 
engineered by inducing the differentiation of NSCs and morphogenesis of differentiated 
cells. Therefore, in vitro NVU model can be considered as the combination of 
angiogenesis model and neurogenesis model. Hence, cell culture conditions for neural 
cells and ECs were investigated to induce neurogenesis and angiogenesis respectively. 
In this thesis, effects of organ-specific ECs on angiogenic microvascular formation 
and its function were first investigated by culturing brain microvascular ECs (BMECs) 
or HUVECs with MSCs in chapter 3, which was an essential milestone in the 
construction of an in vitro BBB model. Next, an in vitro neurogenesis-angiogenesis 
model was established in chapter 4. In chapter 5, culture conditions for a long-term 
triculture of NSCs, BMECs and MSCs were investigated to construct a tissue composed 
of neurons, astrocytes and microvasculatures. Finally, summary and future perspectives 
were described in chapter 6. 
  
Chapter 1 General Introduction 
25 
 
 
Fig. 1-8 Schematic illustration of an in vitro NVU model in a microfluidic device. 
The purpose of this study is the construction of an in vitro NVU model which is 
composed of neurons (orange), astrocytes (blue) and microvasculatures (red) covered by 
pericytes (green). Especially, two characteristics of NVU are focused on; coverage of 
astrocytic endfeet around microvasculatures and close contact between astrocytes and 
neurons (circles). 
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Chapter 2 Materials and methods 
2-1 Cell culture(chapter 3, 4, 5) 
Cells used in this thesis were human brain microvascular endothelial cells (BMECs), 
human umbilical vein endothelial cells (HUVECs), human H9-ESC derived neural stem 
cells (NSCs) and human mesenchymal stem cells (MSCs). 
   BMECs were commercially obtained (Cell Systems Corporation, Kirkland, WA, 
USA). BMECs were cultured in Endothelial Cell Growth Medium-2 BulletKit (EGM-2, 
Lonza, Basel, Switzerland) or CSC complete medium (Cell Systems Corporation), 
depending on experiments. BMECs were expanded in fibronectin-coated culture dishes 
for no more than 7 passages. 
HUVECs were commercially obtained (Lonza). HUVECs were cultured in EGM-2. 
HUVECs were expanded in fibronectin-coated culture dishes for no more than 7 
passages. 
NSCs were commercially obtained (GIBCO, Gaithersburg, MD, USA) and 
expanded in fibronectin-coated culture dishes. NSCs were cultured in NSC medium kit 
(StemProⓇ NSC SFM, GIBCO): Knockout DMEM/F12 with 2% StemProⓇ Neural 
Supplement, 1% GlutaMAX, 20 ng/mL basic fibroblast growth factor (bFGF), 20 
ng/mL epidermal growth factor and 1% Antibiotic-Antimycotic (GIBCO). NSCs were 
expanded for no more than 5 passages. 
Isolation of MSCs was described in a previous study (Yamamoto et al., 2013). 
Briefly, MSCs were isolated from human bone marrow using LNGFR (CD271) and 
Thy-1 (CD90) surface markers. First, bone marrow mononuclear cells (PoieticsTM; 
Lonza) were suspended at 1 to 5 × 107 cells/mL in ice-cold Hank’s balanced salt 
solution supplemented with 2% fetal bovine serum (FBS), 10 mM HEPES and 1% 
penicillin/streptomycin. Next, the cells were stained for 30 minutes on ice with the 
monoclonal antibodies. To eliminate dead cells from the flow cytometric cell sorting 
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(FACS) system, propodium iodide (2 μg/mL) was used. A triple-laser MoFlo (Beckman 
Coulter, CA, USA) or FACSVantage SE (Becton Dickinson, Heidelberg, Germany) 
were used for FACS analysis. 
MSCs were used to promote vascular formation and stabilize vascular structures 
(Yamamoto et al., 2018, 2013). MSCs were cultured in the MSC growth medium: 
Dulbecco’s Modified Eagle Medium with low glucose (DMEM, Invitrogen, Carlsbad, 
CA, USA) supplemented with 20% FBS and 1% Antibiotic-Antimycotic. MSCs were 
expanded for no more than 8 passages. 
 
2-2 Microfluidic device preparation(chapter 3, 4, 5) 
Fabrication processes of the microfluidic device used in this thesis were described in 
detail in a previous study (Shin et al., 2012). Briefly, the microfluidic device was made 
of poly-dimethylsiloxane (PDMS; Silgard184, Dow Corning, Midland, MI, USA) and 
was produced by soft lithography with SU-8 patterned wafers. After peeling the cured 
PDMS from the SU-8 mold, it was cut into pieces and punched out to make media inlets 
and gel inlets. To form microchannels, each device was plasma-bonded with a 
coverglass. Microchannels were filled with 1 mg/mL poly-d-lysine solution 
(Sigma-Aldrich, St. Louis, MO, USA), and the devices were placed in a humidified 5% 
CO2 incubator at 37°C for overnight. The devices were then rinsed twice with sterile 
deionized water and dried at 60°C for 24 hours. 
This microfluidic device has three channels. The central channel, which is filled 
with hydrogel, is sandwiched by two parallel microfluidic channels. The central channel 
has two gel-inlets which are 1.2 mm in diameter, and two microfluidic channels have 
two media-inlets which are 4.0 mm in diameter. The height of each channel is 135 μm. 
The width of the central channel is 750 μm or 1300 μm, which were used depending on 
experiments, and the width of microfluidic channels is 500 μm. 
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2-3 Hydrogel filling and cell seeding in microfluidic devices(chapter 3, 4, 5) 
Fibrinogen, CorningTM MatrigelTM GFR (Growth Factor Reduced) Membrane 
Matrix and hyaluronan (HyStemⓇ Cell Culture Scaffold Kit, Sigma-Aldrich) were used 
as gel scaffolds for cell culture in microfluidic devices. 
Fibrinogen was dissolved in phosphate buffered saline (PBS) to prepare pre-gel 
solution. The final concentration of fibrinogen solution was 4 mg/mL in chapter 3, and 2 
mg/mL in chapter 4 and chapter 5. In chapter 4 and chapter 5, Matrigel and hyaluronan 
were additionally used with fibrinogen. The final concentration of Matrigel was 2, 4 or 
8 mg/mL, depending on experiments. The final concentration of hyaluronan was 2 
mg/mL. Pre-gel solutions of Matrigel and hyaluronan were mixed with fibrin pre-gel 
solution to make fibrin-Matrigel solution and fibrin-hyaluronan solution before injection 
into microfluidic devices. Pre-gel solution was injected through the two gel inlets 
immediately after thrombin (10 units/mL, Sigma-Aldrich) was added to the solution to 
start gelation. After the gel injection, devices were placed in a humidified 5% CO2 
incubator at 37 °C for 30 minutes to complete polymerization of the pre-gel solution. 
When injecting pre-gel solution, it was easily confined within the central channel 
because of surface tension between PDMS posts (Shin et al., 2012). After gelation, 
microfluidic channels were filled with culture medium from media inlets. The 
microfluidic devices were kept in an incubator until use. 
BMECs, HUVECs, NSCs or MSCs were suspended in their own culture medium 
after these cells were dissociated from culture dishes using TrypLE (GIBCO). The cell 
concentration was 1 × 106 cells/mL for all cell types. After aspirating culture medium 
from reservoirs of a microfluidic device, 1 × 104 cells were seeded in the microfluidic 
device through media reservoirs. When seeding cells, devices were tilted by 90° to 
allow cells to adhere to the gel surface between trapezoid posts. After cell seeding, 
devices were incubated for 30 minutes in a humidified 5% CO2 incubator at 37 °C to 
complete the cell attachment on the gel surface. 
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Culture medium was exchanged every day. Phase-contrast images were taken every 
day to monitor the process of cell migration and morphogenesis. 
 
2-4 Immunocytochemistry 
2-4-1 Immunofluorescence staining procedures(chapter 3, 4, 5) 
For the imaging of constructed neurites and microvasculatures, cells were fixed with 
4% paraformaldehyde for 15 minutes at room temperature and permeabilized with 0.1% 
Triton X-100 (Sigma-Aldrich) for 5 minutes. After permeabilization, the cells were 
treated with BlockAce (Dainippon Pharmaceutical, Japan) for 1 hour to block 
non-specific staining. The cells were then incubated at 4°C overnight with primary 
antibodies. Thereafter, the cells were incubated with secondary antibodies at room 
temperature for 2 hours. The cells were finally incubated with 
4′,6-diamidino-2-phenylindole (DAPI; Invitrogen) for staining cell nuclei. The cells 
were rinsed with PBS between each step. 
   Z-stack fluorescence images were taken by a confocal laser-scanning microscope 
(LSM 700, Carl Zeiss, Germany). Two-dimensional projection immunofluorescence 
images were generated with the z-stack images using ImageJ (National Institutes of 
Health, Bethesda, MD, USA). 
 
2-4-2 Antibodies(chapter 3, 4, 5) 
Primary antibodies used in this thesis are as follows: 
(product name; source; catalog number; company; dilution) 
 
BMECs and HUVECs 
Human CD31/PECAM-1 Antibody; sheep; AF806; R&D Systems; 1:100. 
VE-Cadherin (D87F2) XPⓇ Rabbit mAb; rabbit; #2500; Cell Signaling Technology; 
1:100. 
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ZO-1 Monoclonal Antibody (ZO-1-1A12); mouse; 33-9100; Thermo Fisher Scientific; 
1:50. 
Occludin Polyclonal Antibody; rabbit; 71-1500; Thermo Fisher Scientific; 1:100. 
 
Pericytes differentiated from MSCs 
Monoclonal Anti-Actin, α-Smooth Muscle antibody produced in mouse; mouse; A2547; 
Sigma-Aldrich; 1:200. 
Anti-PDGFR beta antibody [Y92] – C-terminal; rabbit; ab32570; abcam; 1:100. 
Human NG2/MCSP PE-conjugated Antibody; mouse; FAB2585P; R&D Systems; 1:50. 
 
Basement membranes 
Anti (mouse) Laminin; mouse; LB-1013; LSL; 1:200. 
Anti Collagen IV α5(IV) Chain, Human (Mono); rat; C-452-EX; Chigei Medical 
Research Institute; 1:50. 
 
NSCs 
Purified anti-Tubulin β3 (TUBB3) [Tuj1]; mouse; 801202; BioLegend; 1:500. 
Microtubule associated protein 2 (MAP2) Antibody (M13); mouse; 13-1500; Thermo 
Fisher Scientific; 1:100. 
GFAP Polyclonal Antibody; rabbit; PA5-16291; Thermo Fisher Scientific; 1:100. 
Anti-Galactocerebroside Antibody, clone mGalC; mouse; MAB342; Merck Millipore; 
1:100. 
Anti-Human/Mouse SOX2 Monoclonal Antibody; mouse; MAB2018; R&D Systems; 
1:100. 
Anti-Nestin antibody – Neural Stem Cell Marker; rabbit; ab92391; abcam; 1:200. 
 
   Secondary antibodies (1:100 dilution) and the antibody for staining cell nuclei 
(DAPI, 1:250 dilution) used in this thesis were purchased from Invitrogen. 
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2-5 Quantitative analysis 
2-5-1 Microvasculatures(chapter 3, 4) 
Quantitative analyses were performed for sprout and microvascular length, sprout 
number, branch points, vessel outer diameter and pericyte number. Microvascular length 
was quantified using z-stack immunofluorescence images of engineered 
microvasculatures. After 2D projection images were generated with z-stack images of 
microvasculatures, sprout length and microvascular length in the 2D projection images 
were traced using the freehand line tool in ImageJ. The length of the traced lines was 
measured to quantify sprout length and microvascular length. Sprout number and 
branch point were quantified by manually counting the sprout number and branch points 
in each image. Vessel diameter was measured at 1/3 and 2/3 of the width of the central 
channel along the Y-axis. Pericyte number was quantified by counting 
α-SMA-expressing cell nuclei on the outer surface of microvascular configurations. 
Quantitative analyses of junction proteins were also performed using ImageJ. After 
thresholding each immunofluorescence image, image calculator, a plugin of ImageJ, 
was used to calculate fluorescence intensity of junction proteins in ECs constituting 
microvasculatures. 
 
2-5-2 Neurites(chapter 4) 
Neurite length was measured by the same method of measuring microvascular 
length. To quantify the number of three-dimensionally migrating cells, cell nuclei which 
located at least 15-μm far from the top or bottom surfaces of a 3D hydrogel scaffold 
were counted using ImageJ. This counted cell number was divided by the total cell 
number in the 3D hydrogel scaffold to calculate the percentage of cells in 3D region. 
 
2-5-3 Gel collapse in triculture of NSCs, BMECs and MSCs(chapter 4) 
Gel collapse occurred in triculture experiments in chapter 4. The quantification of 
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gel collapse was performed using ImageJ by surrounding the devoid area in each 
z-projection image. 
 
2-5-4 Dextran perfusion and measurement of microvascular permeability 
coefficient(chapter 3) 
To analyze microvascular permeability, fluorescein isothiocyanate-conjugated 
dextran (FITC-dextran, 2000 kDa) or Texas Red-conjugated dextran (70 kDa) were 
introduced into engineered microvasculatures. After aspirating culture medium from 
reservoirs of a microfluidic device, 10 μL of 50 μg/mL FITC-dextran or Texas 
Red-dextran solution was added to a microchannel containing seeded ECs and MSCs. 
Fluorescence images were obtained every 10 seconds using the 20 × objective lens of a 
confocal laser-scanning microscope (LSM 700). 
Permeability coefficients (P) of BMEC/HUVEC microvasculatures were calculated 
using Fick’s First Law. In general, Fick’s First Law is represented by the following 
equation: 
 𝐽 = −𝐷
𝑑𝑐m
𝑑𝑥
          (1) 
where J is the flux of solute across microvascular wall, D is the diffusion coefficient of 
solutes in endothelial monolayer constituting microvascular wall and cm is the 
concentration of the solute inside EC membrane. When the width of the cell membrane 
is given by d, concentrations of solutes at the intravascular border (cm (0)) and 
extravascular border (cm (d)) are represented using a partition coefficient β as: 
𝑐m(0) = β𝑐1          (2) 
𝑐m(𝑑) = β𝑐2          (3) 
where c1 is the concentration of solutes in microvascular lumen and c2 is the 
concentration of solutes in extravascular region. Substitution of equations (2) and (3) 
into equation (1) yields: 
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𝐽 = −𝐷
𝑑𝑐m
𝑑𝑥
= −𝐷
𝑐m(𝑑) − 𝑐m(0)
𝑑
=
𝐷β(𝑐1 − 𝑐2)
𝑑
          (4) 
Equation (4) shows that the flux is in proportion to the concentration difference between 
intravascular region and extravascular region. It is difficult to determine each 
proportionality constant of Dβ/d individually. Therefore, these constants are expressed 
in a single constant P as a permeability coefficient, yielding the following equation. 
𝐽 = 𝑃(𝑐1 − 𝑐2)          (5) 
   Permeability coefficient is calculated from the flux of solute for a concentration 
difference (c0) across an area of microvascular wall (S) using Fick’s First Law 
(Adamson et al., 1994; Bichsel et al., 2015; Kim et al., 2013). 
𝑃 = 𝐽 ×
1
𝑐0
          (6) 
The flux J is calculated from the rate of the transport of dextran molecules (N) across 
the microvascular wall after the microvasculature was filled with the dextran solution. 
𝐽 =
𝑑𝑁
𝑑𝑡
×
1
𝑆
          (7) 
The concentration c0 is represented using the amount of dextran molecules that initially 
fill the microvasculature. 
𝑐0 =
𝑁0
𝑉
          (8) 
where V is the volume of the microvasculature. It is assumed that the number of solute 
molecules was proportional to the fluorescence intensity (I), substitution of equations 
(7) and (8) into equation (6) yields 
𝑃 =
𝑉
𝑆
×
𝑑𝐼 𝑑𝑡⁄
𝐼0
          (9) 
where I0 is the initial intravascular fluorescence intensity, and dI/dt is the change in 
fluorescence intensity per unit time in the extravascular region. It was assumed that the 
microvascular lumens were circular.  
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𝑆 = 2π𝑟𝑙          (10) 
𝑉 = π𝑟2𝑙          (11) 
where r is the microvascular radius and l is microvascular length. Substitution of 
equations (10) and (11) into equation (9) yields 
𝑃 =
𝑟
2
×
𝑑𝐼 𝑑𝑡⁄
𝐼0
          (12) 
Permeability coefficient P was calculated using equation (12). 
 
2-5-5 Statistical analysis 
   Experiments were repeated three times to confirm the reproducibility of results. 
Data were represented as means ± SEM. Welch’s t-test was used to test for differences 
between the two groups, which were considered statistically significant at p < 0.05. 
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Chapter 3 Comparison of organ-specific endothelial 
cells in terms of microvascular formation and 
endothelial barrier functions 
3-1 Introduction 
Microvascular networks are essential for correct organ functioning. Each organ has 
its own vascular characteristics and functions that are maintained through interactions 
between ECs and parenchymal cells within vascular niches (Géraud et al., 2014). 
Angiocrine and paracrine factors secreted by ECs regulate organ homeostasis and 
function (Rafii et al., 2016), and the fundamental function of microvascular networks is 
to deliver oxygen and nutrients throughout organs. ECs that coat microvascular walls 
adhere to each other through junction proteins such as VE-cadherin, occludin, and ZO-1 
(Abbott et al., 2010; Greene and Campbell, 2016). While the transport of 
macromolecules and undesired substances such as neurotoxins out of the 
microvasculature is strongly inhibited by endothelial barrier functions, ECs regulate the 
active transport of nutrients and oxygen into the organ parenchyma by paracellular and 
transcellular pathways (Abbott et al., 2010; Barar et al., 2016; Greene and Campbell, 
2016). In addition to this universal function, ECs display slightly different features 
depending on the organ in which they reside. Notably, brain ECs cooperate with 
astrocytes and pericytes to form a characteristic vascular microenvironment called BBB 
(Zhao et al., 2015). Brain microvascular networks strictly prohibit the transport of toxic 
substances to the brain parenchyma and effectively transfer compounds essential for 
brain homeostasis. On the other hand, ECs of the kidney glomeruli and liver effectively 
maintain active transport of blood-borne molecules to the parenchyma (Ben-Zvi et al., 
2014; Géraud et al., 2014). In addition to these morphological features of organ-specific 
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ECs, ECs from different organs exhibit tissue-specific expression profiles of 
transcription factors, angiocrine growth factors, adhesion molecules, and chemokines 
(Nolan et al., 2013). Such differences in both the structural organization and function of 
organ-specific ECs suggest that organ specificity should be considered when 
investigating interactions between ECs and other cell types constituting a target organ. 
The brain has organ-specific ECs that play important roles in the functioning of the 
BBB. Many studies have investigated BBB development and functions because the 
regulation of the BBB is important for both drug delivery and drug screening (Banerjee 
et al., 2016; Bicker et al., 2014). Transport properties of the brain capillary endothelium 
and interactions between ECs and perivascular cells, such as pericytes and astrocytes, 
have also been the focus of previous studies (Banerjee et al., 2016; Helm et al., 2016; 
Keaney and Campbell, 2015; Sweeney et al., 2018). By culturing ECs with pericytes 
and/or astrocytes, cell culture systems have been observed to mimic in vivo 
microvascular environments. In some studies, a Transwell cell culture system was used 
to obtain TEER measurements that were further analyzed to estimate endothelial barrier 
functions. These studies established that endothelial barrier function is augmented when 
ECs are cultured with astrocytes and pericytes. However, the ECs in these studies 
formed a two-dimensional (2D) monolayer rather than a native in vivo 
three-dimensional (3D) capillary structure. It has also been reported that ECs isolated 
from brain capillaries tend to lose their barrier properties (Banerjee et al., 2016). In 
addition, ECs are covered by pericytes and astrocytic endfeet and the percentage of 
pericyte coverage around capillaries are the highest in the brain compared to the other 
organs (Armulik et al., 2010; Daneman et al., 2010; Keaney and Campbell, 2015; 
Thomsen et al., 2017; Trost et al., 2016; Zlokovic, 2008). These fundamental features of 
brain capillaries were not included in previous in vitro studies, highlighting the disparity 
between in vitro BBB models and native EC conditions in vivo. 
To bridge this gap, it is imperative that a successful 3D brain microvascular network 
be constructed. An in vitro BBB model requires two key features: the construction of 
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functional capillary-level microvascular networks and the coverage of pericytes and 
astrocytic endfeet around the microvasculatures. The construction of capillary-level 
microvasculatures is particularly challenging, especially in terms of capillary diameter: 
indeed, most previously reported microvasculatures have been between 20 and 100 μm 
in diameter (Kim et al., 2015, 2013; Nguyen et al., 2013), much larger than that of real 
capillaries. Toward the establishment of an in vitro BBB model, construction of 
capillary-level microvascular networks with pericyte coverage was first focused on. 
Previous studies that have constructed in vitro microvascular networks have used 
microfluidic cell culture platforms in which cells were cultured in 3D gel scaffolds 
mimicking an in vivo ECM (Kim et al., 2015; Kim et al., 2013). We created an 
angiogenesis model using ECs and MSCs (Yamamoto et al., 2018). HUVECs were used 
in these studies. 
In this chapter, a microfluidic cell culture platform was developed by coculturing 
BMECs and MSCs, an essential milestone in the construction of an in vitro BBB model. 
To compare the characteristics of organ-specific ECs, HUVECs were also cultured with 
MSCs as opposed to BMECs. MSCs were used in the coculture because of their ability 
to differentiate into pericytes both in vivo (Koike et al., 2004) and in vitro (Yamamoto et 
al., 2018, 2013). Whether organ-specific ECs would affect vascular formation processes 
and whether microvascular networks constructed using such ECs would exhibit their 
own characteristics in terms of endothelial barrier functions and fundamental 
morphology were assessed in this chapter. 
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3-2 Experimental design 
   Detailed methods for the experiments described in this chapter are summarized in 
chapter 2. Here, experimental settings are described below. 
 
Microfluidic device: 
   Schematic illustrations of the microfluidic device used in this chapter are shown in 
Fig. 3-1. This microfluidic device has three microchannels. The central channel is used 
as cell culture channel by injecting gel scaffolds. Two parallel microfluidic channels are 
used as media channels. 
   The width of the central channel is 750 μm, The width was determined by 
preliminary experiments. When ECs and MSCs are seeded in one microfluidic channel 
in the 750-μm device, they elongate vascular structures and these vasculatures reach the 
opposite side of the channel about 5-7 days. The penetration of microvasculatures 
across the central channel is needed to perfuse dextran solutions into the 
microvasculatures to investigate endothelial barrier functions. Therefore, we used the 
750-μm device for EC-MSC cocultures. 
   The width between trapezoidal posts is 50 μm, which is determined by following 
reasons. First one is to prevent the leakage of gel solutions out of the central channel 
when injected. Gel solutions are easily fixed in the central channel because of the 
surface tension between these posts (Huang et al., 2009; Shin et al., 2012). Second is to 
minimize the undesired leakage of fluorescent dextran solution from microfluidic 
channel to the central channel. When constructing microvasculatures, some spaces exist 
between microvasculatures and trapezoidal posts. Some of the solutes of fluorescent 
dextran solution can pass through the space, which may diffuse throughout the central 
channel. To avoid this, the width between each post was set to be 50 μm. Microfluidic 
devices whose width between posts was 30 μm was tried to make, only to find it 
difficult to produce these devices stably. 
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Cells: 
   BMECs, HUVECs and MSCs were used in this chapter. The amount of all cell types 
seeded in each device was 1.0 × 104 cells. The ratio of ECs and MSCs was 1:1, which 
was optimized in a previous study (Yamamoto et al., 2013). 
   Angiogenesis is the growth of new blood vessels from pre-existing ones. 
Endothelial vascular sprouts are formed by degrading surrounding ECM around blood 
vessels through production of matrix metalloproteinases (MMPs). ECs and MSCs were 
seeded on the gel surface between each post in order to mimic angiogenic processes in a 
microfluidic device. Cultured ECs proliferate and form vascular-like structure inside the 
microfluidic channel where cells are seeded. Some ECs migrate into the gel scaffold and 
form vascular sprouts. These sprouts are elongated and become mature by the coverage 
of pericytes which are differentiated from MSCs. It was reported that the differentiation 
of MSCs into pericytes was induced by culturing MSCs with ECs (Koike et al., 2004; 
Yamamoto et al., 2018). 
 
Medium: 
   For all experiments in this chapter, 1:1 mixture of EGM-2 and MSC growth medium 
was used. 
 
Additional supplement to medium: 
   The medium was supplemented with 10 ng/mL VEGF and 10 ng/mL bFGF to 
promote cell proliferation and microvascular formation. 
 
Gel scaffold: 
   Fibrin (4 mg/mL) was used for all experiments in this chapter because fibrin has 
been widely used as a gel scaffold for EC culture to induce angiogenic processes in vitro 
(Dietrich and Lelkes, 2006; Kim et al., 2013; Nakatsu and Hughes, 2008). 
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Dextran perfusion experiments: 
   To analyze endothelial barrier function of constructed microvasculatures, 
fluorescent dextran perfusion was performed. Molecular weights of the dextran were 
2,000 kDa or 70 kDa. The 2,000 kDa dextran was used to test if the dextran solution 
would be perfused without instant leakage out of vessels. The measurement of 
microvascular permeability was performed using 70 kDa dextran solution. Some in vitro 
or in vivo studies demonstrated fluorescent dextran perfusion into constructed vascular 
structures or cerebral microvessels of rats (Alimperti et al., 2017; Bang et al., 2017; 
Kim et al., 2013; Sobrino et al., 2016; Yuan et al., 2009). There are many kinds of 
fluorescent dextran in terms of molecular weight, and 70 kDa dextran has been mostly 
used in previous studies because the molecular weight is closest to that of human 
albumin (66 kDa), which was reported to be neurotoxic (Hassel et al., 1994). Therefore, 
70 kDa dextran was used not only to test the endothelial barrier function but also to 
compare the result to previous studies. 
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Fig. 3-1 Schematic illustration of an EC-MSC coculture in a microfluidic device. 
A: A microfluidic device and an enlarged image of its central channel filled with fibrin 
gel (gel region). The central channel is sandwiched between two microchannels filled 
with cell culture media (microfluidic channels). Fibrin gel pre-polymer solution was 
injected into the central channel from two gel inlets (arrowheads) immediately after 
thrombin was introduced to the pre-polymer solution. Culture medium was added using 
the inlets of the microfluidic channels (arrows) following gel polymerization. B: 
Schematic illustrations of cell seeding and microvascular formation. A cell suspension 
of ECs and MSCs was added to one microfluidic channel and cells were allowed to 
attach to the side wall of the fibrin gel (left). ECs migrated into the fibrin gel to form 
microvascular structures (red) covered with pericytes differentiated from MSCs (green) 
(right). 
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3-3 Results 
3-3-1 Initial vascular sprout formation in BMEC/HUVEC-MSC cocultures 
First, an early stage of microvascular formation recapitulated by BMEC-MSC 
coculture and HUVEC-MSC coculture was focused on. ECs and MSCs were cultured 
together in a microfluidic device (Fig. 3-1). Both ECs and MSCs were seeded in the 
same microchannel and attached to the surface of the gel region (Fig. 3-2A, Day 0). 
These cells then actively migrated into the gel region from the start of coculture 
regardless of EC origin (Fig. 3-2A, Day 2, arrowheads). Corresponding phase-contrast 
images demonstrated that these cells migrated across the gel region within 3 days of 
seeding (Fig. 3-2A, Day 3). Immunofluorescence images showed that vascular sprouts 
stained with PECAM-1 were formed by day 3 (Fig. 3-2B, arrowheads). Quantitative 
analyses of the immunofluorescence images revealed that both sprout number and 
microvascular length were significantly greater in HUVEC-MSC cocultures than in 
BMEC-MSC cocultures (Fig. 3-2B–D). These results suggest that vascular formation in 
the early stage is different depending on EC origin. 
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Fig. 3-2 An early stage of EC-MSC coculture. A: Phase-contrast images of 
BMEC-MSC (left) and HUVEC-MSC (right) cocultures on days 0–3. Arrowheads 
indicate migrating cells at the front edge. B: Representative immunofluorescence 
images of ECs and MSCs on day 3. Arrowheads indicate vascular sprouts stained with 
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PECAM-1 (green). Cell nuclei were stained with DAPI (blue). C: Quantitative analyses 
of the number of EC sprouts. D: Quantitative analyses of microvascular length. Data are 
shown as the mean ± SEM (N=3, n ≥ 9). *p<0.05. 
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3-3-2 Microvascular network formation in BMEC/HUVEC-MSC cocultures 
Next, EC-MSC cocultures until day 7 were performed to observe the extension and 
the maturation of constructed microvasculatures. According to phase-contrast 
microscopy, the number of migrating cells into the gel region was increased on day 7 
compared to that on day 3 (Fig. 3-3A versus Fig. 3-2A). Microvascular networks were 
constructed by day 7 regardless of EC origin, which was observed by 
immunofluorescence staining of microvascular structures with PECAM-1, α-SMA and 
DAPI (Fig. 3-3B). Enlarged images showed that some perivascular cells expressing 
α-SMA, which were derived from MSCs, existed closely around microvascular 
configurations (Fig. 3-3C). 
To evaluate microvascular formation by BMECs and HUVECs, characteristics of 
microvasculatures formed by these ECs were compared. Specifically, quantitative 
analyses were performed for microvascular length, branch points, outer diameter, and 
pericyte number. As expected from the results of vascular formation in the early stages 
as shown in Figure 3-2, HUVECs formed more complex microvascular networks 
compared to BMECs. The length of constructed microvascular networks was greater in 
HUVEC-MSC cocultures than in BMEC-MSC cocultures (Fig. 3-3E). Branch points 
were also greater in HUVEC-MSC cocultures (Fig. 3-3F), but microvascular outer 
diameter did not differ between cell types (Fig. 3-3G). Finally, pericyte numbers were 
comparable between cocultures (Fig. 3-3H). 
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Fig. 3-3 A late stage of EC-MSC coculture. A: Representative phase-contrast images 
of ECs and MSCs on day 7 (left: BMEC-MSC, right: HUVEC-MSC). B: Corresponding 
immunofluorescence images of ECs (PECAM-1, red) and perivascular cells (α-SMA, 
green) on day 7. Cell nuclei were stained with DAPI (blue). C: Enlarged images of 
constructed microvasculatures, corresponding to boxes 1 and 2 in panel B, respectively. 
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D: Orthogonal views of constructed microvasculatures showing microvascular 
diameters. E-H: Quantitative analyses of microvascular length (E), branch point (F), 
microvascular outer diameter (G), and pericyte number (H) in both BMEC-MSC and 
HUVEC-MSC cocultures. Data are shown as the mean ± SEM (N=3, n ≥ 9). *p<0.05. 
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3-3-3 Basement membrane formation and pericyte coverage around 
microvasculatures 
Next, the formation of basement membranes and the coverage of pericytes around 
microvasculatures, which are important stages in vascular maturation, were investigated. 
Immunofluorescence staining revealed that basement membrane proteins such as 
laminin and type IV collagen were expressed along with microvasculatures regardless 
of EC origin (Fig. 3-4A, 3-4B). Laminin was localized in the basal domain of the 
microvascular configurations (arrowheads, Fig. 3-4A), suggesting that ECs constituting 
microvasculatures recognized apical-basal polarity. Type IV collagen was localized in 
the outer space of microvasculatures. Some type IV collagen was co-expressed with 
α-SMA (arrows, Fig. 3-4A), suggesting potential cooperation between ECs and MSCs 
in type IV collagen production. In terms of pericyte coverage, we performed 
immunofluorescence staining of microvasculatures for pericyte markers, NG2 and 
PDGFRβ, in addition to α-SMA. These markers were also expressed in perivascular 
cells in both BMEC-MSC and HUVEC-MSC cocultures (Fig. 3-4C, 3-4D). 
Cross-sectional images showed that these pericytes wrapped PECAM-1-positive 
microvasculatures. These results indicate that the constructed microvasculatures became 
mature and stabilized within 7 days of EC-MSC coculture. 
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Fig. 3-4 Immunofluorescence staining for basement membrane proteins and 
pericytes. Representative immunofluorescence images of constructed 
microvasculatures (PECAM-1), pericytes (α-SMA, NG2 and PDGFRβ), basement 
membrane proteins (laminin and type IV collagen), and cell nuclei (DAPI) on day 7 in 
BMEC-MSC coculture (A, C) and HUVEC-MSC coculture (B, D). Arrowheads indicate 
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laminin localization around microvasculatures. Arrows indicate the colocalization of 
α-SMA and type IV collagen. Perivascular cells, which were positive for NG2 and 
PDGFRβ, were observed around microvasculatures (C, D). Cross-sectional images 
corresponding to the dotted lines in C and D showed the coverage of pericytes around 
microvasculatures. 
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3-3-4 Permeability assay of microvascular walls using fluorescent dextran 
solution 
Next, endothelial barrier function of 7-day-old microvasculatures constructed from 
either BMECs or HUVECs was tested because the BBB is a specific feature of 
neurological tissue. Fluorescent dextran solution was perfused into microvascular 
networks, and time-lapse imaging was performed to investigate the time course of the 
dextran distribution. First, introducing fluorescent dextran solution into constructed 
capillary-level microvasculatures with diameter < 10 μm (Fig. 3-5A–C) was 
successfully performed. Cross-sectional images of microvasculatures clearly 
demonstrated that the luminal space was filled with the dextran solution without leakage 
(Fig. 3-5B). Next, the diffusion of the dextran solution from the intravascular region to 
the extravascular region was analyzed. Quantitative analyses of the fluorescence 
intensity showed that the intensity of the dextran solution significantly decreased across 
the capillary wall (Fig. 3-5D). To analyze endothelial barrier function, the time 
transition of fluorescence intensity of dextran in the extravascular region within 3 μm 
from the capillary wall was quantified. The extravascular fluorescence intensity 
increased gradually with increasing time in both BMEC and HUVEC microvasculatures 
(Fig. 3-5E). The permeability coefficients of 70 kDa dextran solution across capillary 
walls were 0.9 ± 0.4×10-7 cm/s for BMEC microvasculatures and 2.7 ± 0.6×10-7 cm/s 
for HUVEC microvasculatures, respectively (Fig. 3-5F). These results indicate that the 
endothelial barrier function of BMEC microvasculatures was significantly more robust 
than that of HUVEC microvasculatures. 
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Fig. 3-5 Fluorescent dextran perfusion into constructed microvasculatures.  
A: Immunofluorescence image of microvascular networks filled with FITC-dextran 
solution (2000 kDa). Dextran solution was introduced into microvascular networks on 
day 7. B: An enlarged image corresponding to the box in panel A and cross-sectional 
images of a dextran-perfused capillary (diameter < 10 μm). C: Immunofluorescence 
image of a dextran-perfused capillary on day 7. Fluorescent dextran solution (Texas red; 
70 kDa) was introduced into microvascular networks. D: Representative fluorescence 
intensity distribution in intravascular and extravascular regions quantified along the axis 
of the white line in panel C. E: Representative time transition of fluorescent dextran 
intensity in extravascular regions. F: Quantitative analyses of permeability coefficients 
0
0.5
1
1.5
2
2.5
3
3.5
×
0.9
1.1
1.3
0 50 100 150
0
5
10
15
20
25
30
35
40
0 5 10 15 20
*
Chapter 3 Comparison of organ-specific endothelial cells 
53 
 
for perfused microvasculatures in BMEC-MSC and HUVEC-MSC cocultures. Data are 
shown as the mean ± SEM (N=3, n ≥ 3). *p<0.05. 
  
Chapter 3 Comparison of organ-specific endothelial cells 
54 
 
3-3-5 Junction protein expression in microvascular networks
It was hypothesized that the different permeabilities of the different 
microvasculatures were related to differences in endothelial junctional properties, in 
particular the greater tightness of BMEC microvascular walls. Therefore, 
immunofluorescence staining of endothelial junction proteins such as VE-cadherin, 
ZO-1, and occludin was performed to investigate the junctional properties of 7-day-old 
microvasculatures. VE-cadherin was expressed in intercellular regions and the 
cytoplasm of both BMECs and HUVECs (Fig. 3-6A, VE-cadherin). ZO-1 was localized 
in intercellular regions and the cytoplasm of BMEC microvasculatures while that in 
HUVEC microvasculatures was found only in cytoplasmic regions (Fig. 3-6A, ZO-1). 
Occludin was expressed in the cytoplasm of both BMECs and HUVECs contributing 
towards microvasculature structures (Fig. 3-6A, Occludin). 
Quantitative analyses of VE-cadherin expression showed no significant differences 
between BMEC and HUVEC microvasculatures (Fig. 3-6B). Conversely, expression 
levels of ZO-1 and occludin were significantly higher in BMEC microvasculatures (Fig. 
3-6C, 3-6D). These results demonstrated that the endothelial junctional properties 
differed by EC origin. 
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Fig. 3-6 Junctional properties of constructed microvasculatures in EC-MSC 
cocultures. A: Immunofluorescence images of constructed microvascular networks 
stained with VE-cadherin, ZO-1, occludin, PECAM-1 and DAPI. VE-cadherin, ZO-1, 
and occludin were expressed in the constructed microvasculatures. Arrowheads indicate 
intercellular expressions of junction proteins. Dotted lines in the enlarged image of 
HUVEC-MSC ZO-1 represent the microvascular configuration. B, C, D: Quantitative 
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analyses of VE-cadherin (B), ZO-1 (C), and occludin (D) expressions in the 
microvasculatures. Data are shown as the mean ± SEM (N=3, n ≥ 12). *p<0.05. 
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3-3-6 Inflammatory response of BMEC microvasculature induced by thrombin
Finally, the inflammatory response of microvasculatures was tested focusing on 
BMECs because it is important for the study of BBB in pathological states. BMEC 
microvasculatures were incubated with culture medium supplemented with 1 unit/mL 
thrombin to induce an inflammatory response. Before thrombin stimulation, the 
fluorescent dextran solution introduced in a microchannel passed through the 
microvascular networks across the gel region (Fig. 3-7A, 3-7C). The dextran solution 
came out of open ends of microvasculatures toward the other microchannel. The 
fluorescent dextran solution was detected in the other microchannel, the intensity of 
which increased with time (Fig. 3-7A, asterisks). However, the BMEC 
microvasculatures became leaky following thrombin stimulation (Fig. 3-7B). Although 
the solution was detected in the other microchannel, the increase in intensity was 
attenuated (Fig. 3-7B, asterisks). Moreover, it was detected throughout extravascular 
regions of the gel scaffold (Fig. 3-7B), suggesting that it passed across the walls of 
microvasculatures. To quantify these observations, fluorescence intensity of the 
dextran-perfused microvasculatures was measured along the line across 
microvasculatures (Fig. 3-7C, enlarged image). The time-series of fluorescence intensity 
profiles clearly showed that fluorescence intensity corresponding to extravascular 
regions increased with increasing time after thrombin stimulation (Fig. 3-7C–E, open 
circles). 
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Fig. 3-7 Inflammatory response of BMEC microvasculatures. A: Time-lapse images 
of microvasculatures perfused with the dextran solution on day 5. Images were obtained 
every 30 s for 330 s using a confocal microscope. Asterisks represent FITC-dextran 
solution detected in the other microchannel, which passed through the 
microvasculatures. B: Time-lapse images of the thrombin-treated microvasculatures 
perfused with dextran solution on day 5. Asterisks represent the dextran solution 
detected in the other microchannel. The fluorescence intensity in extravascular spaces 
within the gel region was significantly increased after thrombin stimulation. C: A 
●
* * * * * *
*
* *
○●○
● ●○○
○ ○● ●
x [μm]
Chapter 3 Comparison of organ-specific endothelial cells 
59 
 
merged image of phase-contrast and fluorescence images of microvasculatures perfused 
with FITC-dextran solution (2000 kDa) on day 5. Dotted lines in enlarged image 
represented microvascular configurations. D, E: Quantitative analysis of fluorescence 
intensity before thrombin stimulation (D) and after stimulation (E) along the straight 
line in the enlarged image in panel C. Fluorescence intensity of three different time 
points (t=0s, 150s, 330s) were shown together. Open circles inside dotted straight lines 
represent extravascular region and closed circles inside dotted straight lines represent 
intravascular region. 
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3-4 Discussion 
An in vitro angiogenesis model using BMECs/HUVECs and MSCs was 
demonstrated in this chapter. Both microvasculatures had continuous lumens with 
average diameters close to 10 μm. In addition, the microvasculatures were sparsely 
covered by pericytes and expressed basement membrane proteins such as laminin and 
type IV collagen. These results indicate that the engineered microvasculatures were 
stable. Furthermore, introducing fluorescent dextran solution into the microvascular 
networks was successfully performed and their endothelial barrier functions were 
analyzed. The calculated permeability coefficients of BMEC and HUVEC 
microvasculatures were 0.9 ± 0.4×10-7 cm/s and 2.7 ± 0.6×10-7 cm/s, respectively. These 
permeability coefficients are close to that of in vivo microvessels (Shi et al., 2014; Yuan 
et al., 2009). Permeability coefficients of in vitro microvasculatures perfused with 70 
kDa dextran were also measured, which ranged from 4.5×10-7 to 2.0 ×10-6 cm/s (Bichsel 
et al., 2015; Lee et al., 2014; Sobrino et al., 2016). Taken together, these data indicate 
that the constructed microvasculatures had robust barrier functions. A previous study 
demonstrated that microvessels constructed by HUVEC-pericyte coculture showed 
more robust endothelial barrier function than those constructed by only HUVECs 
(Bichsel et al., 2015). Constructed microvasculatures in this chapter were covered by 
α-SMA-expressing pericytes, suggesting that endothelial barrier function was supported 
by these pericytes and through interactions between ECs and pericytes. 
It was shown here that microvascular networks can indeed be constructed in 
BMEC-MSC as well as HUVEC-MSC coculture systems. Notably, the 
microvasculatures of different cell origin had different features. For example, both 
sprout formation and microvascular length were greater in HUVEC-MSCs than in 
BMEC-MSCs on day 3, the initiation stage of vascular formation. Previous studies have 
reported that MSCs produce angiogenic factors such as VEGF and bFGF (Bronckaers et 
al., 2014; Nassiri and Rahbarghazi, 2014; Volarevic et al., 2011). The results in this 
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chapter suggest that HUVECs were more sensitive to angiogenic factors than BMECs, 
or that HUVECs have greater potential than BMECs in terms of vascular formation, 
which might be due to their organ-specific characteristics. BMEC and HUVEC 
microvasculatures were also compared on day 7, the maturation stage of vascular 
formation. Similar to the initiation stage of vascular formation, HUVECs constructed 
more extensive networks in terms of both microvascular length and branch points. 
However, there were no significant differences between BMECs and HUVECs in terms 
of vessel diameter and the number of pericytes covering microvasculatures. A previous 
study reported that brain capillaries have higher pericyte coverage than any other 
capillaries (Daneman et al., 2010). Further investigation is needed to clarify whether 
reported differences in pericyte coverage are observed in EC-MSC cocultures 3D 
models in this chapter. 
Pericytes stabilize capillary structures through the Ang1-Tie2 signaling pathway, 
resulting in inhibition of angiogenic processes (Armulik et al., 2005; Ribatti et al., 2011). 
The construction of microvascular networks was realized in two possible steps: EC 
sprout formation and elongation, and the stabilization of capillary networks by the 
coverage of pericytes differentiated from MSCs. In addition, the expression of basement 
membrane proteins such as laminin and type IV collagen were observed in both BMEC 
and HUVEC microvasculatures, suggesting that engineered microvasculatures were 
both stable and mature within 7 days of culture. 
Fluorescent dextran perfusion into constructed microvascular networks was 
performed to compare endothelial barrier functions. Instant leakage was not observed. 
Furthermore, the permeability coefficient was significantly lower in BMEC 
microvasculatures. This indicates a more robust barrier function in BMEC 
microvasculatures. Tight junction proteins such as ZO-1 and occludin are key 
components that regulate endothelial paracellular barrier functions (Greene and 
Campbell, 2016; Reinhold and Rittner, 2017). VE-cadherin is also a key regulator of 
endothelial barrier functions (Dejana, 1996; Gavard, 2014; Koch and Claesson-Welsh, 
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2012). Therefore, the difference in barrier function observed in this chapter might be 
attributable to the junctional properties of each constructed microvasculature. To verify 
this, immunofluorescence staining for VE-cadherin, ZO-1, and occludin was performed. 
The expressions of ZO-1 and occludin were significantly higher in BMEC 
microvasculatures than in HUVEC microvasculatures, while VE-cadherin expression 
was confirmed in both microvasculatures at the same level. These data indicate that the 
lower permeability coefficients of BMEC microvasculatures are attributable in part to 
the higher expression of tight junction proteins. VE-cadherin and ZO-1 were localized 
in intercellular regions while occludin was not. Further investigation on occludin 
localization in intercellular region and its effect on endothelial barrier functions is 
required. 
Finally, the potential of the engineered BMEC microvasculatures was demonstrated. 
A previous study presented an in vitro vascular model using HUVECs with bone 
marrow stromal cells to mimic barrier function and analyze the role of mural cells in 
vascular inflammation (Alimperti et al., 2017). Inflammatory factors such as 
lipopolysaccharides, thrombin, and tumor necrosis factor α have been used to induce an 
inflammatory response in vasculatures in vitro. Vasculatures treated with thrombin have 
shown the greatest increase in permeability among these inflammatory factors, and 
thrombin disrupts tight junctions (Hassanpour et al., 2017) and VE cadherin-dependent 
cell–cell contact (Konstantoulaki et al., 2003). Therefore, thrombin was selected as an 
inflammatory factor, and it was found that BMEC microvasculatures showed leaky 
characteristics after treatment. This suggests that in vitro BMEC-MSC coculture model 
in this chapter recapitulated an endothelial response to the proinflammatory stimulus, 
which may potentially be of use in the study of BBB pathologies. 
In conclusion of this chapter, BMEC-MSC and HUVEC-MSC cocultures were 
performed to establish an in vitro brain angiogenesis model, and the effects of EC origin 
on the formation of microvasculatures were compared. The formation process differed 
depending on EC origin. Moreover, BMEC and HUVEC microvascular networks 
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exhibited different characteristics in terms of endothelial barrier functions as well as 
fundamental morphology. In addition, the inflammatory response of microvasculatures 
constructed with BMECs was also demonstrated. These results suggest that the organ 
source of ECs has to be considered when creating an organ-specific cell culture model 
because the organ-specificity can affect interactions between microvasculatures and 
parenchymal cells in the model. 
 
3-5 Summary 
Every organ demonstrates specific vascular characteristics and functions maintained 
by interactions of ECs and parenchymal cells. Particularly, brain ECs play a central role 
in the formation of a functional BBB. Organ-specific ECs have their own morphological 
features, and organ specificity must be considered when investigating interactions 
between ECs and other cell types constituting a target organ. Here, angiogenesis-based 
microvascular networks with perivascular cells were constructed in a microfluidic 
device setting by coculturing ECs and MSCs. Furthermore, endothelial barrier functions 
were analyzed as well as fundamental morphology, which was an essential step to build 
an in vitro BBB model. In particular, both BMECs and HUVECs were used to test if 
organ specificity of ECs affects the formation processes and endothelial barrier 
functions of an engineered microvascular network. It was found that microvascular 
formation processes differed by the source of ECs. HUVECs formed more extensive 
microvascular networks compared to BMECs while no differences were observed 
between BMECs and HUVECs in terms of both the microvascular diameter and the 
number of pericytes peripherally associated with the microvasculatures. To compare the 
endothelial barrier functions of each type of EC, fluorescent dextran perfusion on 
constructed microvasculatures was performed. The permeability coefficient of BMEC 
microvasculatures was significantly lower than that of HUVEC microvasculatures. In 
addition, there were significant differences in terms of tight junction protein expression. 
Chapter 3 Comparison of organ-specific endothelial cells 
64 
 
These results suggest that the organ source of ECs influences the properties of 
engineered microvasculature and thus is a factor to be considered in the design of 
organ-specific cell culture models. 
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Chapter 4 Integration of neurogenesis and angiogenesis 
models for constructing a neurovascular tissue 
4-1 Introduction 
The brain consists of neural tissues including neurons and glial cells, blood vessels 
wrapped by smooth muscle cells or pericytes, and ECM. The brain cells interact with 
each other both structurally and functionally. For example, endothelial tight junctions 
form BBB to control the transport of substances to the brain parenchyma, and it is 
known that astrocytes and pericytes around blood vessels contribute to the regulation of 
BBB functions (Abbott et al., 2010; Wilhelm and Krizbai, 2014). This brain-specific 
structure is now well-known as the concept of NVU, which is a basic unit in the brain. 
In the field of brain tissue engineering, many studies have been conducted using single 
cell type, e.g. either neurons or glial cells, to simplify an experimental model. However, 
as the concept of NVU has been proposed, it becomes increasingly important to 
investigate interactions among brain cells for further understanding of brain functions 
and developing therapeutics of brain disorders. Therefore, it is necessary to construct a 
brain tissue with multiple cell types in vitro, which allows us to analyze the interactions 
of brain cells in NVU. 
In vitro NVU culture models have been reported to recapitulate brain specific 
functions (Palmiotti et al., 2014). Especially, a Transwell assay has been used to analyze 
the function of brain ECs by coculturing ECs and astrocytes or pericytes (Wilhelm and 
Krizbai, 2014; Wong et al., 2013). These studies revealed that the expression of tight 
junction proteins increased in ECs when they were cocultured with astrocytes or 
pericytes. However, ECs were cultured two-dimensionally on a plastic dish or a cell 
culture insert, which are much stiffer than the ECM substrate exposed to cells in vivo. 
The difference in cell configuration and substrate stiffness may cause a different 
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morphogenesis of ECs in 2D culture compared to those in physiological conditions. To 
overcome the gap between 2D culture and in vivo conditions, it is required to develop a 
3D culture model where neural and vascular networks can be constructed in an ECM 
scaffold. 
Previous in vitro NVU culture models mimicked a specific structure of NVU in 
which an endothelial monolayer was in close proximity with astrocytes or pericytes 
(Booth and Kim, 2012; Wong et al., 2013). In these models, differentiated glial cells or 
pericytes were used to construct such a specific structure. However, ECs formed a 
monolayer in these models while ECs form vascular structures in vivo. To construct 
vascular structures, ECs are required to be cultured in 3D gel scaffolds to mimic 
angiogenesis, which is a multi-step morphogenesis of ECs and mural cells. Such a 3D 
gel scaffold also provides an environment for neural cells to mimic neurogenesis, which 
is also a multi-step process including neural differentiation from NSCs and neurite 
extension. Construction of a neurovascular tissue is realized through these processes, 
suggesting that the combination of in vitro neurogenesis and angiogenesis models is a 
critical step toward the NVU construction in vitro. 
In this chapter, a 3D cell culture model in a microfluidic platform is presented, 
which allows us to construct neurovascular tissues by triculture of human NSCs, 
BMECs and human MSCs. As a first step, constructing neurovascular tissues including 
three-dimensionally extensive neurons and capillaries was focused on, because 
construction of neurovascular tissues is essential for the next step to construct a 3D 
NVU structure including neurons, capillaries and glial cells. In the present study, cells 
were cultured in ECM gel scaffolds composed of fibrin, Matrigel and hyaluronan. The 
effect of the gel components on both neurogenesis and angiogenesis was investigated to 
construct neurovascular tissues. The timing of cell seeding and cell distribution were 
also controlled to optimize cell–cell and cell–ECM interactions in the process of 
neurogenesis and angiogenesis. In terms of angiogenesis, our previous study 
demonstrated that MSCs promoted vascular formation of HUVECs and differentiated 
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into α-SMA-positive perivascular cells (Sudo, 2015). These MSC-derived pericyte-like 
cells sparsely wrapped constructed vasculatures, which had continuous luminal 
structures. Based on these results, it was hypothesized that BMECs could also construct 
vascular structures in BMEC-MSC coculture. The aim of this study was to investigate 
3D microenvironments for culturing NSCs and BMECs with induction of neurogenesis 
and angiogenesis in a microfluidic platform, which is the critical step toward the 
development of an in vitro NVU model. 
 
4-2 Experimental design 
   Detailed methods for the experiments described in this chapter are summarized in 
chapter 2. Here, experimental settings are described below. 
 
Microfluidic device: 
Schematic illustrations of the microfluidic device used in this chapter are shown in Fig. 
4-1. The width of the central channel is 750 μm or 1300 μm. The 750-μm device was 
used for triculture experiments to enhance potential interactions by the diffusion of 
growth factors secreted by both neural and vascular cells. It was demonstrated that 
fluorescent dextran (molecular weight: 40 kDa) injected in one microfluidic channel can 
be transported across a gel region, whose width was 750 μm, by diffusion within 30 
minutes (Sudo et al., 2009). 
 
Cells: 
BMECs, MSCs and NSCs were used in this chapter. The amount of all cell types 
seeded in each device was 1.0 × 104 cells. In triculture experiments, NSCs were 
seeded in one microfluidic channel and BMECs and MSCs were seeded in the other 
microfluidic channel. Neural cells and vascular cells were seeded separately to induce 
neurogenesis from one side and angiogenesis from the other side of the gel region. In 
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NSC pre-seeding condition, NSCs were first cultured alone for 7 days to allow them to 
migrate into the gel region and increase the neuronal population. Triculture was 
performed for additional 3 days to induce neurovascular formation. On the other hand, 
in BMEC-MSC pre-seeding condition, BMECs and MSCs were first cocultured for 7 
days to induce microvascular formation in the gel region. NSCs were then seeded to 
start triculture. Triculture experiments were performed for 10 days for all conditions. 
 
Medium: 
NSC medium was used for NSC monoculture (4-3-1, 4-3-3 and 4-3-4) and triculture 
of NSCs, BMECs and MSCs. BMEC monoculture (4-3-5) and BMEC-MSC coculture 
(4-3-2) were performed using 1:1 mixture of CSC complete medium and MSC growth 
medium. 
 
Additional supplement to medium: The mixture of CSC complete medium and MSC 
growth medium was supplemented with 10 ng/mL VEGF and 10 ng/mL bFGF to 
promote microvascular formation and cell proliferation. 
 
Gel scaffold: Fibrin, Matrigel and hyaluronan were used in this chapter. The reason for 
using fibrin was mentioned in chapter 3 (3-2). Matrigel was commonly used for neural 
cell culture (Bang et al., 2016; Sun et al., 2016; Wevers et al., 2016). In addition, main 
components of Matrigel are laminin and collagen IV, which are components of brain 
ECM (Carbonetto, 1984). Hyaluronan is also a component of brain ECM (Margolis et 
al., 1975; Ripellino et al., 1988). Therefore, Matrigel and hyaluronan were used to test if 
these ECM components would be suitable for the culture of NSCs in terms of neurite 
extension. 
   The concentration of fibrin was 2 mg/mL for all experiments in this chapter. The 
concentration of Matrigel in fibrin-Matrigel mixed gel was 2 mg/mL in the first 
experiment (4-3-1), and 2, 4 and 8 mg/mL in the later experiment (4-3-3). The 
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maximum concentration of Matrigel was set to be 8 mg/mL because it becomes hard to 
seed cells onto the gel wall when the concentration of Matrigel is high. After 
optimization of the condition of gel concentration in 4-3-3, the concentration of 
Matrigel used in later experiments was 8 mg/mL. NSC monoculture (4-3-4) and 
triculture of NSCs, BMECs and MSCs (4-3-5) was performed in fibrin-Matrigel mixed 
gel. The concentration was 2 mg/mL and 8 mg/mL for fibrin and Matrigel, respectively. 
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Fig. 4-1 Schematic illustrations of a microfluidic device. A: A PDMS device copied 
by an SU-8 mold was plasma-bonded with a coverglass to form microfluidic channels. 
Gel pre-polymer solution was then injected into the central channel from two gel inlets 
(arrows). B: There are two parallel microchannels separated by the gel region. BMECs 
and NSCs were injected into one of the microchannels (arrows). 
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4-3 Results 
4-3-1 Neurite formation of neurons differentiated from NSCs in different gel 
scaffolds 
First, NSCs were cultured in a microfluidic device, which includes a 3D gel region 
(Fig. 4-1). In the NSC monoculture, different gel scaffolds were used to optimize the gel 
condition in terms of neurite extension (Fig. 4-2A). NSCs were cultured in different gel 
compositions including fibrin, Matrigel and hyaluronan. Fibrin gel has been commonly 
used for 3D cell culture because of its structural stability. Matrigel and hyaluronan have 
often been used for the culture of neural cells because brain ECM is composed of 
laminin, hyaluronan and other proteins such as chondroitin sulfate proteoglycans 
(Zimmermann and Dours-Zimmermann, 2008). Laminin is the main component of 
Matrigel. Although Matrigel and hyaluronan were tested to use without fibrin, it was 
difficult to form these gels (data not shown). Therefore, fibrin was used as a basal gel 
scaffold and added Matrigel or hyaluronan, resulting in three gel conditions; fibrin gel, 
fibrin-Matrigel mixed gel and fibrin-hyaluronan mixed gel. NSCs were cultured in these 
gel conditions and cell morphology and migration were observed everyday by 
phase-contrast microscopy until day 9. The result showed that, in fibrin gel condition, 
some cells migrated into the gel on day 1 (Fig. 4-2B, Fibrin). These migrating cells 
exhibited a round-shape without neurite extension (e.g., arrowheads in Fig. 4-2B, Fibrin, 
day 1, inset) and the number of migrating cells did not increase until day 9. Similarly, 
NSCs exhibited a round-shape when cultured in fibrin-hyaluronan mixed gel 
(arrowheads, Fig. 4-2B, Fibrin-Hyaluronan, day 1, inset). The number of migrating cells 
gradually increased until day 9. On the other hand, the morphology of NSCs was 
different in fibrin-Matrigel mixed gel; cells extended within the gel (arrows, Fig. 4-2B, 
Fibrin-Matrigel, day 1, inset). In addition, migration of NSCs was the greatest in the gel.  
To further investigate cellular morphology and differentiation of NSCs into neurons, 
immunofluorescence staining of cells on day 9 was performed for a neuronal marker, 
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MAP2. In fibrin gel condition, a few round-shape cells were positive for MAP2 but 
neurite extension was not observed (Fig. 4-2C, Fibrin). In fibrin-hyaluronan mixed gel, 
some NSCs were positive for MAP2 and exhibited short neurite-like structures (Fig. 
4-2C, Fibrin-Hyaluronan). On the other hand, many NSCs in fibrin-Matrigel mixed gel 
were positive for MAP2 and extended neurites (Fig. 4-2C, Fibrin-Matrigel). 
Quantitative analysis of neurite length on day 9 revealed that neurite extension was 
significantly promoted in fibrin-Matrigel mixed gel (Fig. 4-2D). 
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Fig. 4-2 Neurite formation of NSC-derived neurons in different gel scaffolds.  
A: Schematic illustrations of NSC culture for constructing a neural network. B: 
Representative phase-contrast images of NSCs cultured in three different gel scaffolds; 
fibrin (left), fibrin-Matrigel mixed gel (middle) and fibrin-hyaluronan mixed gel (right). 
Arrowheads in insets indicate a round shape of NSCs (Fibrin, Fibrin-Hyaluronan), while 
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arrows in an inset indicate an extended NSCs (Fibrin-Matrigel). C: Representative 
immunofluorescence images of neurons (MAP2, green) and nuclei (DAPI, blue) on day 
9. D: Quantitative analysis of neurite length. Data are shown as the mean ± SEM. (N=3, 
n ≥ 16). *p<0.05 vs. Fibrin. Scale bars, 100 µm. 
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4-3-2 Formation of microvasculature in BMEC-MSC coculture in different gel 
scaffolds 
Next, the same gel conditions, which were fibrin gel, fibrin-Matrigel mixed gel and 
fibrin-hyaluronan mixed gel as tested for NSCs, were tested in terms of capillary 
formation. Coculture of BMECs and MSCs was performed in these gel conditions. First, 
BMECs and MSCs were cultured in fibrin-Matrigel mixed gel to investigate whether 
capillary networks can be formed in the gel condition. BMECs were seeded into one 
channel while MSCs were seeded into the other channel (Fig. 4-3A). On day 1, MSCs 
dominantly migrated into the 3D gel scaffold toward BMECs, while some BMECs 
formed vascular sprouts (arrowheads, Fig. 4-3B, Fibrin-Matrigel, day 1, inset). Both cell 
types increasingly migrated into the gel region until day 9. Because it was difficult to 
distinguish between BMECs and MSCs by phase-contrast microscopy, 
immunofluorescence staining was performed for PECAM-1 and α-SMA, which are 
markers for BMECs and perivascular cells, respectively. The immunofluorescence 
image revealed that BMECs formed vascular sprouts and constructed branching 
microvasculatures while MSCs differentiated into α-SMA-positive perivascular cells on 
day 9. Similar microvasculatures were also formed in fibrin gel, while sheet-like 
structure was observed in fibrin-hyaluronan mixed gel (Fig. 4-3C, Fibrin, 
Fibrin-Hyaluronan, Fig. 4-3D). Quantitative analysis of network length on day 9 
revealed that construction of microvasculatures was the greatest in fibrin-Matrigel 
mixed gel (Fig. 4-3E). In addition, microvasculatures in fibrin-Matrigel mixed gel was 
successfully constructed by culturing BMECs and MSCs in the same microchannel (Fig. 
4-7). 
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Fig. 4-3 Formation of microvasculatures in BMEC-MSC coculture in fibrin, 
fibrin-Matrigel mixed gel, and fibrin-hyaluronan mixed gel. A: Schematic 
illustrations of BMEC-MSC coculture. B, C:  Representative phase-contrast images on 
days 1, 5 and 9, and corresponding immunofluorescence images of BMECs (PECAM-1, 
red), pericytes (α-SMA, green), and nuclei (DAPI, blue) on day 9. Arrowheads in an 
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inset indicates vascular sprouts (Fibrin-Matrigel, day 1). Scale bar, 200 µm. D: An 
enlarged image of cells in the fibrin-hyaluronan mixed gel. Arrowheads indicate a 
sheet-like structure of BMECs. Scale bar, 200 µm. E: Quantitative analysis of network 
length. Data are shown as the mean ± SEM. (N=3, n≥9). *p<0.05 vs. 
Fibrin-Hyaluronan. 
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4-3-3 Optimization of the concentration of fibrin-Matrigel mixed gel 
Following the experimental results above, fibrin-Matrigel mixed gel was used for 
subsequent experiments. Since neurons extend three-dimensionally in the brain tissue, 
3D distribution of NSCs in the gel was investigated. Confocal microscope images 
revealed that Tuj1-positive neurons derived from NSCs migrated into the gel region in a 
2D manner along with the top and bottom surface of the gel region (Fig. 4-4A, C). As 
shown in Fig. 4-2, fibrin-Matrigel mixed gel promoted neurite extension more than 
fibrin gel, which suggested that Matrigel promoted neurite extension. Therefore, the 
fibrin concentration was fixed as 2 mg/mL and Matrigel concentration was increased. 
Specifically, Matrigel concentration was increased to be 4 or 8 mg/mL to form more 
stable gel structure. Consequently, 3D neurite extension was induced when NSCs were 
cultured in the modified gel with higher Matrigel concentrations (Fig. 4-4B, D). To 
quantify this 3D distribution of NSCs, the percentage of the number of cell nuclei in a 
3D region against the entire gel region was calculated (Fig. 4-4E). The number of cell 
nuclei in the 3D region significantly increased as Matrigel concentration increased (Fig. 
4-4F). In particular, the greatest 3D distribution was obtained in 2-8 mg/mL 
fibrin-Matrigel mixed gel, and the percentage was 38 ± 3.7%. 
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Fig. 4-4 Optimization of the concentration of fibrin-Matrigel mixed gel for 3D 
migration of neurons. A–D: Immunofluorescence projection images and corresponding 
3D views of neurons in 2-2 mg/ml and 2-8 mg/ml fibrin-Matrigel mixed gel, 
respectively. Cells were fixed on day 21 and stained for neurons (Tuj1, green) and 
nuclei (DAPI, blue). Scale bar, 100 µm. E–F: Quantitative analysis of the percentage of 
migrating cells in a 3D manner. The number of NSCs migrating into the 3D gel region. 
Data are shown as the mean ± SEM. (N=3, n≥12). *p<0.05 vs. 2-2 mg/ml. 
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4-3-4 The process of neurogenesis and neurite extension in NSC culture 
To further investigate differentiation of NSCs into neurons and the process of 
neurite extension, NSCs cultured in 2-8 mg/mL fibrin-Matrigel mixed gel were fixed on 
days 7, 14 and 21, and immunofluorescence staining was performed for neurons (Tuj1). 
Representative projection images showed that cells on day 7 were positive for Tuj1 but 
exhibited only short processes (Fig. 4-5A, day 7). However, cells on day 14 extended 
neurites, which further extended to form long neurites on day 21 (Fig. 4-5A, day 14, 21). 
According to the histogram of neurite length, the distribution of the neurite length of 
neurons shifted towards longer area as they were cultured for 7, 14 and 21 days, 
suggesting that neurons continuously elongated their neurites until day 21 (Fig. 4-5B). 
The longest neurite length was 139 μm, 300 μm and 445 μm on day 7, 14 and 21, 
respectively. The average neurite length increased in proportion to the culture days (Fig. 
4-5C). The average neurite length was 31 ± 0.6 μm, 51 ± 2.0 μm and 86 ± 2.3 μm on 
day 7, 14 and 21, respectively. 
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Fig. 4-5 The process of neurogenesis in 21-day culture. A: Immunofluorescence 
projection images of NSC-derived neurons in 2-8 mg/mL fibrin-Matrigel mixed gel. 
Cells were fixed on day 21 and stained for neurons (Tuj1, green) and nuclei (DAPI, 
blue). Scale bar, 100 µm. B: A histogram of neurite length on days 7, 14, and 21. C: 
Time course of average neurite length in 21-day culture. Data are shown as the mean ± 
SEM. (N=3, n≥12). 
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4-3-5 Triculture of NSCs, BMECs and MSCs for constructing neurovascular 
tissues
Finally, the NSC culture model, which recapitulates neurogenesis, and BMEC-MSC 
coculture model, which recapitulates angiogenesis, were combined for constructing 
neurovascular tissues. In the triculture, BMECs and MSCs were seeded in one 
microchannel and NSCs were seeded in the other microchannel to separate angiogenesis 
and neurogenesis. When culturing BMECs and MSCs, there are two ways of cell 
seeding; seeding both cell types into one microchannel or seeding BMECs into one 
microchannel and seeding MSCs into the other channel. It was confirmed that 
microvasculatures were constructed in both conditions (Fig. 4-7). Three conditions were 
performed in terms of the timing of cell seeding; “same-day seeding”, “BMEC-MSC 
pre-seeding”, and “NSC pre-seeding”. In the same-day seeding condition, 
BMECs-MSCs and NSCs were seeded on the same day. In the BMEC-MSC pre-seeding 
condition, BMECs and MSCs were seeded in the beginning of the culture, and NSCs 
were added on day 7 after vascular structures were constructed by BMECs and MSCs. 
In the NSC pre-seeding condition, NSCs were seeded in the beginning of the culture, 
and BMECs and MSCs were added on day 7 after NSCs migrated into the gel region 
and extended neurites.  
In the same-day seeding condition, NSCs migrated into the gel region from the 
beginning of the triculture while BMECs started sprouting into the gel region. In the 
BMEC-MSC pre-seeding condition, BMECs also started sprouting into the gel region 
from the beginning of the culture, and some of microvasculatures reached the end of the 
gel region, which is 750 μm far from the seeding point. However, in these seeding 
conditions, the gel structure shrank as vascular sprouts elongated into the gel region 
with increasing culture time (Fig. 4-6A, Same-day seeding, BMEC-MSC pre-seeding). 
Therefore, enough space was not maintained for NSCs to migrate and expand in the 
shrunk gel structure. On the other hand, in the NSC pre-seeding condition, NSCs 
migrated into the gel region before seeding BMECs and MSCs. NSCs differentiated into 
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neurons and elongated neurite structures while microvasculatures were constructed 
inside the same gel region after seeding BMECs and MSCs on day 7 (Fig. 4-6A, NSC 
pre-seeding). The area of the gel collapse was quantified on day 10 of the triculture (Fig. 
4-6B). Gel collapse was significantly reduced in the NSC pre-seeding condition 
compared to the other conditions. In addition, enlarged view of neurons and BMECs in 
the NSC pre-seeding condition showed that microvasculatures and neurites existed in 
close proximity in the gel region (Fig. 4-6C). The constructed neurovascular tissues 
maintained at least for 10 days. 
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Fig. 4-6 Triculture of NSCs, BMECs and MSCs for constructing neurovascular 
tissues. A: Representative phase-contrast images on days 3, 7 and 10, and 
corresponding immunofluorescence images of neurons (Tuj1, green), BMECs 
(PECAM-1, red) and cell nuclei (DAPI, blue) on day 10. Arrowheads and areas 
surrounded by dotted lines in immunofluorescence images represent the gel collapse. 
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Scale bar, 200 μm. B: Quantitative analysis of the gel collapse in different seeding 
conditions on day 10. Data are the means ± SEM. (N=3, n≥9). *p<0.05 vs. “Same day” 
and “BMEC-MSC pre-seeding”. C: Enlarged views of neurons and BMECs in NSC 
pre-seeding condition. Scale bars, 100 μm. 
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Fig. 4-7 Formation of microvasculatures in BMEC-MSC coculture in “same side” 
and “other side” seeding conditions. A: Schematic illustrations of BMEC-MSC 
coculture. B, C:  Representative phase-contrast images on days 0, 4 and 7, and 
n.s.
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corresponding immunofluorescence images of BMECs (PECAM-1, red), perivascular 
cells (α-SMA, green), and nuclei (DAPI, blue) on day 7. Scale bar, 100 µm. D: 
Quantitative analysis of network length. Data are shown as the mean ± SEM. (N=3, 
n≥9). n.s.: no significance. 
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Fig. 4-8 BMEC monoculture in fibrin-Matrigel mixed gel. A: A schematic 
illustration of BMEC culture. B:  Phase-contrast images on days 0, 1, 3, 5 and 7, and 
corresponding enlarged images on days 3, 5 and 7. Scale bar, 100 µm. 
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4-4 Discussion 
In the present study, 3D neurovascular tissues in ECM gel scaffolds were 
successfully constructed by combining 3D angiogenesis and neurogenesis models. In 
the field of tissue engineering, the construction of a 3D NVU structure including 
neurons, glial cells, and blood vessels has not been demonstrated (Osipova et al., 2018). 
Previous studies reported in vitro NVU models using Transwell or microfluidic devices 
that were composed of ECs with/without astrocytes and pericytes to investigate BBB 
functions of ECs (Bicker et al., 2014; Cho et al., 2015; Nakagawa et al., 2009; Wilhelm 
and Krizbai, 2014; Xue et al., 2013). These culture models enabled us to investigate the 
functional characteristics of ECs such as endothelial permeability. However, cells in 
these models were cultured as endothelial monolayers, which is different from in vivo 
conditions. 
Culturing brain cells in an ECM gel scaffold, which is closer to physiological 
conditions than a plastic substrate such as well plates, will enable us to recapitulate 
more physiologically relevant morphogenesis. Brain cells in the Transwell model cannot 
interact with each other in the juxtacrine manner because of the physical compartment, 
while astrocytes and pericytes wrap around blood vessels through the basement 
membrane in a physiological condition (Hawkins and Davis, 2005). This limitation of 
signaling pathway can cause a different morphology of cultured cells compared to those 
in physiological conditions. The stiffness of a plastic surface or coated ECM proteins on 
which cells adhere can also affect the morphology of these cells and differentiation of 
stem cells (Engler et al., 2006; Kothapalli and Kamm, 2013). To overcome such 
limitations in previous 2D NVU models, this cell culture model provided a 3D 
neurovascular tissue that is constructed by inducing neurogenesis and angiogenesis in a 
microfluidic device. The success in recapitulating neurogenesis and angiogenesis 
suggests that this microfluidic culture model provided a proper microenvironment for 
both neural and vascular cells to survive and function. 
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In this chapter, NSCs were first cultured in fibrin gel, fibrin-Matrigel mixed gel and 
fibrin-hyaluronan mixed gel. The proliferation of NSCs and the neurite extension in 
fibrin-Matrigel were significantly promoted compared to the other conditions. It is 
known that various factors can promote or inhibit neurite extension. A composition of 
ECM proteins is one of the important factors in regulating neurite extension. Previous 
studies showed that laminin can guide neurite extension and promote migration of 
growth cone of neurons (Kuhn et al., 1995; Turney and Bridgman, 2005). Neurons bind 
to laminin, which is the main component of Matrigel, through β1 integrin (Hall et al., 
2008; Lei et al., 2012). A previous report showed that axons of neurons which bound to 
laminin expressed a β1 integrin, and laminin/β1 integrin signaling contributed to axon 
development and promoted axon elongation (Lei et al., 2012). Similarly, in the present 
experiments, it is suggested that NSC-derived neurons, which were cultured in 
fibrin-Matrigel mixed gel, bound to laminin and constructed 3D neural networks 
through the laminin/β1 integrin signaling. 
In this neurovascular tissue culture model, NSCs differentiated into neurons and 
they continued elongating neurites at least for 21 days. Relatively short neurites which 
are within 60 μm were observed even on day 21, suggesting that cultured NSCs 
continued generating neurons for 21 days or some neurons stopped elongating their 
neurites in the beginning of the culture but still alive at the end of the culture. It is 
known that neural differentiation of NSCs is followed by glial differentiation (Temple, 
2001). Therefore, it is expected that glial differentiation will be induced by continuing 
the NSC culture in this cell culture model, which will lead to the construction of the 3D 
NVU structure in long-term culture. 
BMECs and MSCs were cocultured in three different gel conditions, fibrin gel, 
fibrin-Matrigel mixed gel and fibrin-hyaluronan mixed gel. It was found that 
microvasculatures with α-SMA-positive perivascular cells were constructed in these gel 
conditions. It was hypothesized that hyaluronan would be suitable to construct brain 
vasculature because it is the main component of brain ECM (Zimmermann and 
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Dours-Zimmermann, 2008). However, interestingly, most cells migrated 
two-dimensionally along the bottom glass surface when they were cultured in 
fibrin-hyaluronan mixed gel. Some microvasculatures were constructed in this condition, 
but sheet-like structures were also constructed resulting from the two-dimensional cell 
migration, suggesting that hyaluronan is not suitable for constructing capillaries. Given 
that hyaluronan is one of the main components of brain ECM and angiogenesis is 
suppressed in mature normal brain, these data suggest that hyaluronan has some 
anti-angiogenic effects which lead to the stabilization of pre-existing vasculature. 
Addition of hyaluronan to hydrogel changed not only biochemical properties of the gel 
but also its mechanical properties. The stiffness of ECM may also affect angiogenic 
processes (Burdick and Prestwich, 2011). For example, it was reported previously that 
the different stiffness of collagen gel led to the different vessel diameter and length in an 
angiogenic process (Chung et al., 2009; Yamamura et al., 2007). Therefore, the further 
investigation will be needed in terms of the effect of biochemical and biomechanical 
cues on angiogenesis to establish a stable in vitro experimental model of NVU tissues. 
In this microfluidic cell culture model, especially in “NSC pre-seeding” condition, 
neurovascular tissues were successfully constructed on day 10 by inducing neurogenesis 
and angiogenesis simultaneously in an optimized 3D ECM gel condition. However, in 
“same-day seeding” and “BMEC-MSC pre-seeding” conditions, the gel structure shrank 
within a few days from the BMEC-MSC side. This collapse of the gel can be explained 
by two factors. First, the gel structure was not strong enough against the traction force 
of BMECs and MSCs when they migrated into the gel. The other possibility is that 
BMECs or MSCs secreted MMPs to degrade the gel. Although there is still a possibility 
of further modification of the gel, the success in constructing neurovascular tissues 
including neurons and microvasculatures is a critical step to achieve the construction of 
NVU structures in vitro. 
In conclusion of this chapter, a microfluidic platform for constructing a 3D 
neurovascular tissue was established. This cell culture model enables us to culture NSCs 
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and ECs three-dimensionally in a close proximity, which is mimicry of brain 
microenvironment composed of neural cells, microvasculatures and ECM. In addition, 
processes of neurogenesis, angiogenesis and the formation of neurovascular tissues can 
be monitored by phase-contrast microscopy. This microfluidic cell culture system has 
such advantages which cannot be achieved by conventional culture systems such as 
Transwell systems. In the future study, the differentiation of NSCs into astrocytes will 
be focused on, which is an additional key element constituting NVU microenvironments. 
A new in vitro NVU model which contains neurons, astrocytes, microvasculatures 
wrapped by pericytes and ECM proteins will be of great use for studies of 
neurovascular interactions and studies of neurovascular development. 
 
4-5 Summary 
NVU is a conceptual basic unit in the brain, including neurons, glial cells, blood 
vessels and ECM. This concept implies the importance of a 3D culture model including 
these cell types for investigating brain functions. However, little is known about the 
construction of an in vitro 3D NVU model. The aim of this study was to construct 3D 
neurovascular tissues by combining in vitro neurogenesis and angiogenesis models 
using a microfluidic platform, which would be a critical step toward the NVU 
construction in vitro. Three gel conditions, which were fibrin gel, fibrin-Matrigel mixed 
gel and fibrin-hyaluronan mixed gel, were investigated to optimize the gel components 
in terms of neurogenesis and angiogenesis. First, fibrin-Matrigel mixed gel was found to 
induce NSC differentiation into neurons and neurite extension. In particular, 3D neurite 
extension was realized in 2-8 mg/mL fibrin-Matrigel mixed gel. Second, it was found 
that microvasculatures were also formed in the fibrin-Matrigel mixed gel by coculturing 
BMECs and MSCs. Finally, both neural and vascular culture models were combined, 
resulting in constructing 3D neurovascular tissues with an optimized seeding condition 
of NSCs, BMECs and MSCs. 
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Chapter 5 Investigation of triculture conditions of NSCs, 
BMECs and MSCs for the construction of NVU-like 
structure 
5-1 Introduction 
   The brain is one of the most complex organs in the human body. Neurons, astrocytes 
and oligodendrocytes are the major brain parenchymal cells that perform brain-specific 
functions. Because of the limited capacity to store energy, neurons need constant supply 
of oxygen and nutrients from blood vessels for proper neuronal activities (Zlokovic, 
2011). Astrocytes contribute to the transport of nutrients from blood vessels to neurons. 
Malfunction of the supply can cause pathological states. Therefore, brain activities and 
homeostasis are maintained by this multi-cellular system composed of neural cells and 
vasculature. This fundamental group of cells is called neurovascular unit (NVU). 
   NVU structure comprises a brain-specific microvascular interface called BBB. Brain 
microvasculatures are covered by pericytes and astrocytes. Brain ECs lining along 
microvascular walls express tight junction proteins such as claudins and occludin. The 
paracellular and transcellular transport of hydrophilic substances are strictly restricted 
by BBB. This brain-specific structure inhibits the active transport of drugs into brain 
parenchyma and makes it difficult for drugs to exert the effects. Therefore, 
understanding of BBB regulation and penetration is critical for drug screening studies 
targeting neurodegenerative diseases. 
   Many in vitro studies have been performed to investigate BBB functions (Banerjee 
et al., 2016; Bicker et al., 2014; Helm et al., 2016). In these studies, brain ECs were 
cultured in a 2D manner, and the barrier tightness of the endothelial monolayer was 
estimated by measuring the resistance of ionic diffusion through endothelial monolayer 
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using TEER approach. However, TEER is an estimate, not a direct analysis of BBB 
function because TEER is unmeasurable for in vivo microvasculatures (Banerjee et al., 
2016). An ideal approach to investigate BBB function is constructing in vivo-like 3D 
brain microvasculatures and perfusing solutions into the constructed microvasculatures 
to measure the transport of solutes through the microvascular wall. 
Microfluidic cell culture platform can potentially be a robust method to realize the 
construction of 3D NVU structures. Microfluidic devices are made through 
microfabrication processes such as photolithography and soft lithography. Microfluidic 
devices are made of PDMS and have designed microchannels. Cells can be cultured 
three-dimensionally within ECM-like gel scaffolds by injecting cells and gel solution 
into the devices. Previous studies demonstrated the engineering of 3D vasculatures by 
culturing HUVECs using microfluidic devices, which was a mimicry of 
neovascularization processes such as vasculogenesis and angiogenesis (Kim et al., 2015, 
2013; Lim et al., 2013). In vitro 3D brain angiogenesis model and 3D neurogenesis 
model were also established previously (chapter 3 and chapter 4). These studies indicate 
the possibility of constructing 3D NVU structure by combining angiogenesis and 
neurogenesis models. However, the construction of the NVU structure composed of 
neurons, astrocytes and microvasculatures has not been achieved. 
If we can construct 3D NVU structures in an in vitro manner, the cell culture system 
will be of great use for studies of BBB development and drug screening studies for 
neurodegenerative diseases. Therefore, the present study was performed to investigate 
cell culture conditions for constructing NVU structures including neurons, astrocytes 
and microvasculatures using microfluidic devices. 
 
5-2 Experimental design 
   Detailed methods for the experiments described in this chapter are summarized in 
chapter 2. Here, experimental settings are described. 
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Neurovascular tissue formation was realized by the induction of neurogenesis and 
angiogenesis in fibrin-Matrigel mixed gel in chapter 4. This tissue was composed of 
neurons and microvasculatures, not including astrocytes. Toward the construction of 
NVU structure, the next step is the generation of astrocytes and the induction of the 
coverage of astrocytic endfeet to microvasculatures. In terms of NSC differentiation, 
astrocyte differentiation follows neuronal differentiation (Ramasamy et al., 2013). It 
suggests that long-term culture of NSCs is needed in our culture model. However, as a 
result of the triculture of NSCs, BMECs and MSCs in chapter 4, gel collapse was 
observed, suggesting the difficulty of long-term triculture experiments. Therefore, 
BMEC-MSC culture conditions were first investigated focusing on cell culture medium. 
Next, triculture experiments were performed for constructing NVU structures. In 
particular, toward the construction of the NVU structure, the generation of astrocytes in 
the triculture model was focused on. 
 
Microfluidic device: 
   The 750-μm device was used for all experiments in this chapter. 
 
Cells: 
   NSCs, BMECs and MSCs were used in this study. The amount of these cells was 1.0 
× 104 cells for each device. In triculture experiments, NSCs were seeded in one 
microfluidic channel, and BMECs and MSCs were seeded together in the other 
microfluidic channel to induce neurogenesis from one side the gel region and 
angiogenesis from the other side of the gel region. 
   Time course of the triculture experiment was shown in Fig. 5-1. NSCs were first 
seeded in microfluidic devices (day 0) and cultured until day 21 using NSC medium in 
order to increase the number of neurons and induce the abundant neurite growth. On 
day 21, BMECs and MSCs were seeded in the microfluidic devices to start their 
triculture changing the medium from NSC medium to the mixture of NSC medium and 
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EGM-2. The triculture was performed until day 31. In this triculture, NSCs were 
cultured for 31 days and BMECs-MSCs were cultured for 10 days. The triculture was 
performed for 10 days, which aimed at the vascular development and astrocyte 
differentiation from NSCs following neuronal differentiation. 
 
Medium: 
   NSC medium, EGM-2 and MSC growth medium were used in this chapter. 
Basically, NSCs were cultured in NSC medium, BMECs were cultured in EGM-2, and 
MSCs were cultured in DMEM (chapter 2). When coculturing BMECs and MSCs, the 
mixture of EGM-2 and DMEM were used (chapter 3). In the triculture in chapter 4, only 
NSC medium was used to culture NSCs, BMECs and MSCs. In addition, the gel 
collapse occurred in the condition, which was caused by BMECs and MSCs (chapter 4). 
Therefore, BMEC-MSC coculture medium conditions were first investigated for the 
induction of angiogenesis without gel collapse. 
   To test if combinations of these culture medium would be effective for inducing 
angiogenesis without obvious gel collapse, BMECs and MSCs were cultured using NSC 
medium alone, the mixture of EGM-2 and MSC growth medium or the mixture of NSC 
medium and EGM-2. Following triculture experiments were performed using the 
mixture of NSC medium and EGM-2. 
 
Additional supplement to medium: 
The mixture of NSC medium and EGM-2 was supplemented with 10 ng/mL VEGF and 
10 ng/mL bFGF to promote vascular formation and cell proliferation. 
 
Gel scaffold: 
The optimized gel scaffold in chapter 4, the mixture of 2 mg/mL fibrin gel and 8 
mg/mL Matrigel, was used in this chapter. 
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Fig. 5-1 Time course of triculture of NSCs, BMECs and MSCs, and schematic 
illustrations of cell seeding. 
NSCs were first seeded in a microfluidic device (Day 0) until day 21. On day 21, 
BMECs and MSCs were seeded in the microfluidic device and started triculture. 
Triculture was performed until day 31. Culture medium was changed on day 21 from 
NSC medium to the mixture of NSC medium and EGM-2. 
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5-3 Results 
5-3-1 BMEC-MSC coculture in combination medium of NSC medium, EGM-2 
and DMEM 
First, cell culture medium conditions for BMEC-MSC coculture were investigated 
to induce angiogenesis without gel collapse. BMECs and MSCs were cultured in a 
microfluidic device using NSC medium or mixture of EGM-2 and DMEM. NSC 
medium is the same culture medium condition for the triculture experiment in chapter 4. 
In NSC medium condition, microvasculatures were constructed on day 7. However, the 
gel structure shrank with increasing culture time (Fig. 5-2, NSC medium). In 
EGM-2-DMEM condition, the ideal cell culture medium condition for microvascular 
formation of BMECs and MSCs, microvasculatures were constructed as well as NSC 
medium condition. Furthermore, no obvious gel collapse was observed in this condition 
(Fig 5-2, EGM-2 + DMEM). These results indicate the possibility to culture BMECs 
and MSCs in fibrin-Matrigel mixed gel, the optimized gel condition in chapter 4, 
without the gel collapse. 
In addition to the two culture medium conditions, BMEC-MSC coculture was 
performed using the mixture of NSC medium and EGM-2. As a result, 
microvasculatures were constructed as well as the other two conditions, and no obvious 
gel collapse was observed in this condition as well as EGM-2 + DMEM (Fig. 5-3). 
Considering all results, the mixture of EGM-2 and DMEM or the mixture of NSC 
medium and EGM-2 was presumed to be suitable for the following triculture 
experiments. The mixture of NSC medium and EGM-2 was concluded to use for the 
next triculture of NSCs, BMECs and MSCs. 
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Fig. 5-2 BMEC-MSC coculture in NSC medium or EGM-2-DMEM mixture. 
Microvascular formation was induced in both culture medium conditions. However, gel 
collapse was observed in the NSC medium condition (grey area with dotted line). 
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Fig. 5-3 BMEC-MSC coculture in the mixture of NSC medium and EGM-2. 
Microvascular formation was induced in this culture medium condition. No obvious gel 
collapse was observed in this condition. 
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5-3-2 NSC monoculture in the mixture of NSC medium and EGM-2 
Next, NSC monoculture was performed for 31 days. In prior study, 3D neurite 
extension was observed on day 21 (chapter 4, Fig. 4-5). Considering that astrocyte 
differentiation from NSCs follows neuronal expansion, NSCs were additionally cultured 
for 10 days, totally 31 days. 
First, NSCs were first cultured in NSC medium until day 31 (Fig. 5-4A, B). This 
condition was the simple extension of prior NSC monoculture study (chapter 4, Fig. 
4-5). After 31 days of NSC monoculture, samples were fixed and immunofluorescence 
staining was performed for Tuj1 and glial fibrillary acidic protein (GFAP), markers for 
neurons and astrocytes, respectively. As a result, NSCs proliferated with increasing 
culture time (Fig. 5-4C). Neurite extension was observed on day 31 (Fig. 5-4D). 
However, no clear GFAP expression was observed (Fig. 5-4E). 
Next, NSCs were cultured in NSC medium until day 21, and the additional culture 
for 10 days was performed using the mixture of NSC medium and EGM-2 (Fig. 5-5A, 
B). Immunofluorescence staining was performed on day 31. As a result, NSCs expanded 
with increasing culture time until day 31 as well as the NSC medium condition (Fig. 
5-5C). Immunofluorescence images showed abundant neurite extension in this 
condition (Fig. 5-5D, E), and the density of extended neurites was higher in the mixture 
of NSC medium and EGM-2 than NSC medium (Fig. 5-5E vs. Fig. 5-4E). In terms of 
GFAP expression, some GFAP-positive cells were observed on day 31 in this culture 
medium condition (Fig. 5-5F). Co-expression of Tuj1 and GFAP was not observed in 
this condition. 
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Fig. 5-4 NSC monoculture in NSC medium until day 31. 
NSCs were cultured for 31 days in NSC medium (A, B). Neurite extension was 
observed as well as the result in chapter 4 (Fig. 4-5) (C, D). GFAP expression was not 
observed in this condition on day 31 (E). 
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Fig. 5-5 NSC monoculture in NSC medium (until day 21) and the mixture of NSC 
medium and EGM-2 (from day 21 to 31). 
NSCs were cultured in NSC medium until day 21 and in the mixture of NSC medium 
and EGM-2 from day 21 to day 31 (A, B). NSCs expanded and elongated abundant 
neurites in fibrin-Matrigel mixed gel (C, D, E). GFAP expression was also observed in 
this condition on day 31 (F). Co-expression of Tuj1 and GFAP was not observed. 
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5-3-3 Triculture of NSCs, BMECs and MSCs to construct a 
neuron-astrocyte-capillary tissue 
Next, triculture of NSCs, BMECs and MSCs was performed for 31 days (Fig. 5-6A). 
NSCs were first monocultured in NSC medium for 21 days, and BMECs and MSCs 
were additionally seeded on day 21 (Fig. 5-1). Triculture was performed for 10 days 
using the mixture of NSC medium and EGM-2 (Fig. 5-6B). NSCs were cultured 31 
days totally. Immunofluorescence staining was performed on day 31. 
As a result, NSCs, BMECs and MSCs actively expanded in the gel region with 
increasing culture time (Fig. 5-6C). In addition to the construction of microvasculatures, 
GFAP-positive cells were also observed in the gel region (Fig. 5-6D, G). GFAP-positive 
astrocytes elongated some processes (Fig. 5-6E, H). No direct contacts of astrocytic 
endfeet and microvasculatures were observed. However, an orthogonal image of Fig. 
5-6E showed that astrocyte existed closely around microvasculatures (Fig. 5-6F, 
orthogonal image along the white dotted line). Tuj1-positive neurons were also detected 
in the same gel region together with microvasculatures and astrocytes (Fig. 5-6G, I). 
These neurons located three-dimensionally with microvasculatures in a 
three-dimensional view of Fig. 5-6I (Fig. 5-6J).  
In this microenvironment, it was confirmed that neurons and astrocytes existed 
closely around microvasculatures. However, the unique structure of NVU, the cell 
arrangement of astrocyte intervention between neurons and microvasculatures was not 
observed. In addition, the coverage of astrocytic endfeet around microvasculatures was 
not confirmed. Further investigation is needed to induce the coverage of astrocytic 
endfeet around microvasculatures and the recapitulation of the unique NVU structure. 
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Fig. 5-6 Triculture of NSCs, BMECs and MSCs in a microfluidic device for 31 days. 
NSCs, BMECs and MSCs were tricultured in a microfluidic device (A). NSCs were first 
cultured for 21 days, and BMECs and MSCs were additionally seeded on day 21. 
Triculture was performed for 10 days, and the total culture days of NSCs were 31 (B). 
Three cell types expanded in the gel region with increasing culture time (C). In addition 
to the construction of microvasculatures, astrocyte differentiation was also confirmed 
(D, E, H). Astrocytes existed closely to microvasculatures (F). Neurons were also 
observed in the same gel region together with microvasculatures and astrocytes (G, I). 
Neurons located three-dimensionally in the gel region close to microvasculatures (J). 
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5-4 Discussion 
In this chapter, cell culture medium conditions for the triculture of NSCs, BMECs 
and MSCs for 31 days were investigated. In chapter 4, neurovascular tissues composed 
of neurons and microvasculatures were successfully constructed. However, gel collapse 
was observed, suggesting the difficulty in extending the culture time to induce astrocyte 
differentiation in the triculture. Therefore, culture medium conditions were first 
investigated to construct microvasculatures without gel collapse. Consequently, culture 
medium including EGM-2 suppressed the gel collapse during angiogenesis. The results 
suggest that EGM-2-derived soluble factors have some effects on BMECs or MSCs in 
terms of the suppression of the gel collapse. Although the mechanisms of suppressing 
gel collapse remain to be elucidated, angiogenesis was successfully induced without the 
gel collapse, which was a critical step for a long-term triculture experiment aiming to 
induce astrocyte differentiation. 
Three conditions were tested for culture medium: NSC medium, mixture of EGM-2 
and DMEM, and mixture of NSC medium and EGM-2. EGM-2 is the medium for 
BMECs, and DMEM is the medium for MSCs (chapter 2). The major difference of 
these medium is in FBS. NSC medium does not contain FBS. EGM-2 contains 2% FBS. 
DMEM as an MSC medium contains 20% FBS. FBS is derived from fetal blood, and a 
commonly used supplement for cell culture medium. FBS includes many factors for cell 
adhesion, growth and survival (Brunner et al., 2010). Effects of FBS on cultured 
embryonic rat cerebral cortical neurospheres were investigated previously (Hung and 
Young, 2006). Neurospheres include NSCs and neural progenitor cells. According to 
this study, FBS promoted astrocyte differentiation from neurospheres, while the 
population of neurons was significantly lowered, suggesting that the supplement of FBS 
is unfavorable for neurons while favorable for astrocytes. The supplement of FBS may 
have some negative effect on neurons. This idea is supported by the fact that neurons in 
in vivo conditions are normally free of substances in blood because of BBB. However, 
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considering the previous study reporting that FBS promoted astrocyte differentiation 
from NSCs (Hung and Young, 2006), FBS may be needed for the triculture to induce 
astrocyte differentiation. The result of NSC monoculture in NSC medium, free of FBS, 
showed that there was no GFAP expression (Fig. 5-4). On the other hand, the 1:1 
mixture of NSC medium and EGM-2, which contained totally 1% of FBS, induced 
astrocyte differentiation from NSCs (Fig. 5-5F). This coincided with the previous report 
(Hung and Young, 2006). It was confirmed that this culture medium condition was 
useful for the construction of microvasculatures without gel collapse (Fig. 5-3). 
Therefore, the mixture of NSC medium and EGM-2 was concluded to use as the 
triculture medium. 
 An NVU-like tissue in ECM gel scaffolds was constructed by combining brain 
angiogenesis and neurogenesis models. This NVU-like tissue was composed of neurons, 
astrocytes and microvasculatures. This result suggests the possibility to construct in vivo 
NVU structure, in which astrocytes exist closely to both neurons and microvasculatures 
and astrocytic endfeet wrap around microvasculatures. Toward the construction of NVU 
structure, the next step is the induction of the coverage of astrocytic endfeet around 
microvasculatures. In the triculture experiment, astrocytes existed closely to 
microvasculatures. However, direct contacts of GFAP-positive astrocytic endfeet to 
microvasculatures were not observed. In vivo astrocytes cover >99% of vascular 
surfaces by their endfeet (Iadecola and Nedergaard, 2007). In addition, it was reported 
that endfeet around capillaries were negative for GFAP and positive for connexin 43, a 
gap junction protein, and AQP 4, a water channel expressed in astrocytes (Iadecola and 
Nedergaard, 2007; Simard et al., 2003). Therefore, further investigation is needed to test 
the expression of these proteins in the engineered NVU-like tissue. 
To induce astrocyte differentiation and the coverage of astrocytic endfeet around 
microvasculatures, additional days may be needed for the triculture. One of the aims of 
the extension of culture time is to increase the number of pericytes existing around 
microvasculatures. A previous study reported that pericyte-deficiency resulted in 
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changes in astrocytic endfeet distribution (Armulik et al., 2010). Pericytes are partly 
sandwiched by ECs and astrocytic endfeet. Therefore, there may potentially be some 
interactions between pericytes and astrocytes in terms of astrocytic endfeet coverage to 
capillaries. The mechanisms of interactions between astrocytes and microvasculatures in 
terms of endfeet coverage are not fully understood. However, the induction of astrocyte 
differentiation from cultured glial-progenitor cells were investigated in a previous study 
(Mabie et al., 1997). This study reported that the effect of bone morphogenetic proteins 
(BMPs) on astrocyte differentiation was similar to the effect of FBS. This suggests that 
FBS includes BMPs and promotes astrocyte differentiation by BMP-dependent manners. 
In addition, it was reported that retinoic acid and leukemia inhibitory factor promote 
astrocyte differentiation from NSCs (Asano et al., 2009). Therefore, addition of such 
factors in the cell culture medium may induce astrocyte differentiation more effectively 
toward the construction of microvasculatures covered by astrocytic endfeet. 
 
5-5 Summary 
In this chapter, cell culture medium conditions were investigated for the triculture of 
NSCs, BMECs and MSCs. In chapter 4, a neurovascular tissue composed of neurons 
and microvasculatures were successfully constructed. To construct NVU structure, it 
was aimed to induce astrocyte differentiation from NSCs. 
To induce astrocyte differentiation, a long-term triculture was needed. However, gel 
collapse was occurred in the triculture in chapter 4. This gel collapse was caused by 
BMECs and MSCs. Therefore, cell culture medium conditions for BMEC-MSC 
coculture were first investigated to induce angiogenesis without the gel collapse. 
Consequently, it was found that the mixture of NSC medium and EGM-2 was suitable 
for inducing angiogenesis without the gel collapse in BMEC-MSC coculture. 
In NSC monoculture experiments, astrocyte differentiation was not confirmed when 
NSCs were cultured in NSC medium, while astrocyte differentiation was induced by 
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changing medium from NSC medium to the mixture of NSC medium and EGM-2 on 
day 21 in 31 days-monoculture. Using this cell culture medium condition, an NVU-like 
tissue composed of neurons, astrocytes and microvasculatures was constructed on day 
31. It was confirmed that astrocytes and neurons located closely to microvasculatures 
respectively. However, the direct contact between astrocytic endfeet and 
microvascualtures and the unique structure of NVU, astrocyte intervention between 
neurons and microvasculatures were not confirmed. Further investigation will be needed 
to construct NVU structures in vitro by an additional cell culture period or addition of 
soluble factors that are known to promote astrocyte differentiation. 
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Chapter 6 Concluding remarks 
6-1 Summary 
This thesis deals with neurovascular tissue engineering using NSCs, BMECs and 
MSCs toward the construction of NVU structures in vitro. NVU is a conceptual basic 
unit in the brain, which is composed of neurons, glial cells, microvasculatures and ECM. 
Toward the construction of NVU structure, there are some points to be considered. One 
of them is BBB. BBB is a brain-specific endothelial barrier and BBB microvasculatures 
are composed of ECs, pericytes and astrocytic endfeet. Another is the unique cell 
arrangement, in which astrocytes exist between neurons and microvasculatures through 
astrocytic endfeet. To realize the construction of NVU structure, inducing neurogenesis 
and angiogenesis in 3D ECM gel scaffolds was focused on. 
In chapter 3, an in vitro brain angiogenesis model was established by coculturing 
BMECs and MSCs in a microfluidic device. The formation processes and endothelial 
barrier functions were compared with BMEC microvasculatures and HUVEC 
microvasculatures. This study was motivated by the brain-specific endothelial barrier, 
BBB. Every organ has its own vascular functions, and organ-specificity of ECs has to 
be considered to construct a targeted tissue such as BBB microvasculatures. The results 
in chapter 3 showed significant difference between BMEC microvasculatures and 
HUVEC microvasculatures in terms of endothelial barrier function and expressions of 
tight junction proteins. The study in chapter 3 suggests the importance of using 
brain-specific ECs toward the establishment of an in vitro BBB model. 
Toward the construction of NVU structures in vitro, cell culture conditions were 
investigated to construct a neurovascular tissue composed of neurons and 
microvasculatures by culturing NSCs, BMECs and MSCs in chapter 4. The brain 
angiogenesis model in chapter 3 was performed using fibrin gel as a cell culture scaffold. 
However, it was found that fibrin-Matrigel mixed gel was more suitable for the 
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expansion and neurite extension of neurons differentiated from NSCs than fibrin gel 
alone. On the other hand, it was confirmed that brain angiogenesis was induced within 
the fibrin-Matrigel mixed gel as well as fibrin gel. In addition, 3D neurite extension was 
induced within the mixed gel. Finally, brain angiogenesis model and neurogenesis 
model were combined to construct neurovascular tissue. The results in chapter 4 suggest 
the possibility of constructing NVU structure in the fibrin-Matrigel mixed gel. 
The constructed neurovascular tissue in chapter 4 was composed of neurons and 
microvasculatures. Considering that in vivo NVU structure is composed of neurons, 
astrocytes and microvasculatures, astrocyte differentiation from NSCs was focused on 
as a next step. In terms of the process of NSC expansion and differentiation, astrocyte 
generation follows the generation of neurons (Ramasamy et al., 2013; Temple, 2001). 
Therefore, it was hypothesized that astrocyte generation would be realized by extending 
the period of the triculture of NSCs, BMECs and MSCs. However, in the triculture 
study (chapter 4), gel collapse was observed, suggesting the difficulty in extending 
culture time. Following this result, conditions of cell culture medium in BMEC-MSC 
coculture were first investigated to induce angiogenesis without the gel collapse. As a 
result, microvasculatures were constructed without the obvious gel collapse in the 1:1 
mixture of NSC medium and EGM-2. The condition of cell culture medium was 
concluded to use for the following triculture experiments in addition to the optimized 
condition of the gel scaffold in chapter 4. 
Triculture of NSCs, BMECs and MSCs was performed in the optimized cell culture 
condition until 31 days after astrocyte differentiation was confirmed in the NSC 
monoculture for 31 days. As a result, an NVU-like tissue composed of neurons, 
astrocytes and microvasculatures was constructed. This in vitro microfluidic cell culture 
model has a potential to succeed in engineering in vivo NVU structures. 
Although the in vitro microfluidic cell culture platform in this study still have some 
points to be solved, this study provided some important advantages toward the 
establishment of an in vitro NVU model. First, this microfluidic cell culture system 
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provided a stable model to realize the construction of capillary-level brain 
microvascular networks covered by pericytes. As far as I know, this is the first in vitro 
cell culture model of brain angiogenesis. Some previous studies reported in vitro 
angiogenesis models using HUVECs (Kim et al., 2015, 2013; Lim et al., 2013; Moya et 
al., 2013). These studies successfully induced vascular formation in 3D gel scaffold. 
However, the diameter of the constructed vasculatures is ranged from 20 μm to 150 μm, 
and most of these studies did not focus on the coverage of pericytes around 
microvasculatures, which implied the difficulty of engineering in vivo-like capillary 
structures. Second, this microfluidic cell culture system demonstrated the perfusion of 
fluorescent dextran solution into the constructed capillary-level microvasculatures. 
Brain capillaries have a specific barrier called BBB. The in vitro BBB model described 
in chapter 3 is a critical step to establish an in vitro NVU model, which will possibly be 
established by combining the BBB model with a neural cell culture model described in 
chapters 4 and 5. 
In chapter 5, NVU-like tissue was constructed by the triculture of NSCs, BMECs 
and MSCs. A previous study reported microfluidic cell culture systems in which neural 
cells and ECs were cultured together in microfluidic devices (Adriani et al., 2017). This 
previous study investigated effects of neural cells on endothelial barrier functions and 
effects of ECs on neuronal growth and maturation, which is important for understanding 
interactions among neural cells and ECs. However, cultured ECs in this cell culture 
system form endothelial monolayer, not vascular lumen structures. It is important to 
construct in vivo-like microvascular structures to analyze barrier functions of 
microvasculatures in NVU structures. The in vitro NVU model in this thesis solved this 
problem by culturing BMECs with MSCs together in a microfluidic device. 
So far, in vitro cell culture models aiming at construct NVU structures have not 
provided in vivo-like NVU structures in which microvasculatures are covered by 
pericytes and astrocytic endfeet and astrocytes exist between microvasculatures and 
neurons physically and functionally. The main contribution of the study in this thesis is 
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the construction of an NVU-like tissue composed of microvasculatures, neurons and 
astrocytes. The important point of the study in this thesis is that this in vitro cell culture 
model demonstrated the construction of the NVU-like tissue by recapitulating 
angiogenesis and neurogenesis simultaneously in one gel region. This in vitro cell 
culture system still have challenges to be solved. However, the fact that the construction 
of the NVU-like tissue was induced by self-organization processes such as angiogenesis 
and neurogenesis implies that this model is potentially of use for constructing in 
vivo-like NVU structures and investigating the development processes, which might not 
be recapitulated by the simply-mixed cell culture model using differentiated cells. 
 
6-2 Future perspectives 
An ideal in vitro NVU model is the mimicry of in vivo NVU structures. Key features 
of NVU were as follows: BBB microvascular networks including capillaries with the 
coverage of pericytes and astrocytic endfeet, neuronal network with synaptic activit ies, 
astrocyte regulation of synaptic activities, oligodendrocyte myelination of neurons and 
so on. In particular, in this thesis, BBB microvasculatures and 
neuron-astrocyte-microvascular tissue formation was focused on. By constructing NVU 
structures in vitro, the cell culture system can be applied to drug screening studies for 
neurodegenerative diseases and studies for the understanding of pathological states of 
NVU. Previous in vitro brain disease models have been performed using neural cells, 
not including vasculatures (Yi et al., 2015). Therefore, these models still have 
limitations related to the lack of vasculatures. The in vitro cell culture system in this 
thesis will potentially solve the pre-existing problems in drug screening studies; the 
difficulty of predicting BBB penetration of drugs and following drug efficacy on neural 
cells (Osaki et al., 2018a). These major problems in drug screening and drug 
development processes are difficult to solve by in vitro models composed of only neural 
cells. These problems are also difficult to solve by in vivo studies because of cost and 
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time for tests and ethical problems. 
In addition to the application of the in vitro model to drug screening studies, the cell 
culture system can also be applied to studies of developmental morphogenesis such as 
BBB formation processes. Mechanisms of BBB development is still unclear, and 
monitoring the processes is quite difficult in in vivo studies because of present technical 
problems. This in vitro microfluidic cell culture system has a potential to become a 
robust tool for such studies by recapitulating development processes of BBB and 
monitoring these morphological changes. 
The next step following this thesis will be the induction of astrocytic endfeet 
coverage around microvasculatures. A previous study reported that Ang-2, an 
angiogenic factor, induced astrocyte apoptosis via integrin signaling (Yun et al., 2016). 
The level of Ang-2/Tie-2 signaling is decreased in the angiogenic maturation stage in 
which pericytes cover around vascular lumen (Ribatti et al., 2011). This suggests that 
astrocytes start to cover around vascular lumen with pericytes from this time point. This 
idea is supported by the fact that astrocytes cover both ECs and pericytes (Abbott et al., 
2010; Keaney and Campbell, 2015). To investigate this hypothesis, it is needed not only 
to extend culture time but also to regulate the supply of such angiogenic factors in the 
microfluidic cell culture system by adding these factors in the cell culture medium. 
To investigate whether the direct coverage of astrocytic endfeet around 
microvasculatures are well-organized, it is needed to confirm the expression of proteins 
such as connexin 43, AQP 4, which are expressed in the interface between astrocytes 
and microvasculatures when they are well-organized (Simard et al., 2003). Endothelial 
expression of BBB-specific transporters is also needed to be confirmed. These 
investigations will support the integrity of the engineered NVU structures. 
In addition to the assessment of morphological features of engineered NVU 
structures, the assessment of their function is also needed. In terms of microvascular 
function, the point is that ECs constituting microvasculatures are connected with each 
other by junctional proteins and these microvasculatures have an endothelial barrier 
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which restricts the undesired leakage of solutes flowing in the microvasculatures. It was 
confirmed that the in vitro brain angiogenesis model in chapter 3 met such 
characteristics. On the other hand, it is needed to make it clear that neurons in the NVU 
model in this thesis are functional. Previous studies performed Ca2+ imaging for 
cultured neurons using microfluidic devices to analyze neuronal activities (Adriani et al., 
2017; Osaki et al., 2018b). In the NVU model in this thesis, although cultured neurons 
were positive for Tuj1 or MAP2, functions of these neurons were not assessed. However, 
neuronal activities can potentially be analyzed in this model by applying the techniques 
reported previously. As a next step of this study, the assessment will be important for 
investigating interactions between neurons and other cell types such as astrocytes and 
ECs. 
In chapter 3, in vitro brain angiogenesis model was established in which fluorescent 
dextran solution was perfused into the engineered microvasculatures. If the construction 
of the NVU structure is realized, dextran perfusion into the astrocyte-covered 
microvasculatures will be performed to investigate the astrocytic regulation of 
endothelial barrier functions. Astrocytic endfeet coverage around microvasculatures can 
be monitored in a microfluidic device. By analyzing microvascular permeability before 
and after astrocyte-microvascular development, mechanisms of BBB development will 
potentially be investigated. The potential availability to use this cell culture system for 
studies of BBB development is one of the advantages of this cell culture system, which 
recapitulates self-organization processes. Furthermore, the study can be applied to drug 
screening studies by focusing on the transport of biomolecules from blood to astrocytes, 
or even to neurons. After the achievement of the construction of the NVU structure, the 
next step will be the investigation of functions of the engineered NVU structure, which 
is a multi-cellular system. This microfluidic cell culture system will become a robust 
tool not only for the fundamental study of brain functions but also for the drug 
screening study as a therapeutic strategy. 
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